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Abstract 
Cardiac, State, and Trait Anxiety in Patients Awaiting Invasive Cardiac Procedures in 
Outpatient Preprocedural Unit 
Binu Shajimon, MSN, CRNP-BC 
H. Michael Dreher, Supervising Professor, PhD, RN, FAAN 
 
BACKGROUND: Cardiovascular disease (CVD) is associated with life threatening 
conditions.  Invasive cardiac procedures that are used for diagnosis and treatment of CVD 
provoke anxiety.  Hence, individuals waiting to undergo invasive cardiac procedures may 
experience cardiac anxiety (CA), state anxiety (SA), and/or trait anxiety (TA).  A high 
level of anxiety exemplifies the complexity of psychosomatic and physiological effects 
that influence the outcome of cardiac procedures and the treatment and prognosis of 
CVD.  This study addressed the gap in evaluating the level of the preprocedural anxiety 
(CA, SA, and TA) and determined the difference in CA, SA, and TA in male and female 
patients admitted for invasive cardiac procedures so that the specific anxiety could be 
identified and properly treated and managed.  
DESIGN: A cross-sectional descriptive study design was used.  A study sample of 92 
patients who met the inclusion criteria were recruited from 113 consecutive patients 
admitted in an outpatient preprocedural unit for invasive cardiac procedure. 
METHODS: On procedure day, the participants filled out the Cardiac Anxiety 
Questionnaire-Revised (CAQ-R), Spielberger State-Trait Anxiety Inventory form –Y 
(STAI-Y), and the Demographic Data Form while waiting in the outpatient preprocedural 
unit.   
RESULTS: ANCOVA analysis revealed that there was no significant difference in CA, 
SA, or TA between male and female patients.  A significant difference was found in SA 
 xi 
in participants with and without heart disease and in CA in patients with and without a 
history of HTN.  However, Pearson correlation (r) analyses showed significant 
correlation among the three variables: A moderate correlation between SA and TA (r = 
0.55; p < .05); and a fair correlation between CA and SA (0.22) and between CA and TA 
(0.25).  A stepwise regression analysis revealed that annual income was the most 
significant predictor of CA, a history of heart disease of SA, and no predictors 
contributed to TA. 
CONCLUSION: Participants with TA demonstrated significant SA, and those with low 
income and a diagnosis of heart disease had significant CA.  
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1. INTRODUCTION 
 Cardiovascular disease (CVD) is the leading cause of death and disability in the 
United States (U.S.) and worldwide (Thom et al., 2006; White, 2008).  The diagnosis of 
heart disease provokes anxiety in patients despite advanced technologies in management 
and treatment of CVD.  There is growing evidence that anxiety is an independent risk 
factor for CVD, as it associated with the development of arrhythmias and sudden cardiac 
death (Albert, Chae, Rexrode, Manson, & Kawachi, 2005; Frasure-Smith, Lesperance, & 
Talajic, 1995; Moser & Dracup, 1996).  Studies have shown a connection between 
cardiac symptoms and anxiety, but few investigators have studied cardiac anxiety (CA), a 
persistent type of anxiety in patients with and without known heart disease who are 
undergoing outpatient invasive cardiac procedures.  CA is unrecognized and 
underappreciated which may increase visits to medical practitioners and emergency 
rooms and increase the need for unwarranted cardiac procedures (Eifert, 1992).  Failure 
to identify and treat patients with CA makes them vulnerable to the adverse effects of 
anxiety.  Early detection of the distinct type of anxiety in preprocedural settings could 
enable clinicians to tailor specific, individual-based treatment approaches which are vital 
to improve health status, reduce complications, and ensure treatment success.  Therefore, 
this study proposes to address this gap and demonstrate the predominance of clinically 
relevant CA in patients waiting for cardiac procedure.  It could also add to the CA 
research literature in the domain of preprocedural anxiety.   
 Invasive cardiac procedures like cardiac catheterization or electrophysiological 
study often provoke anxiety in patients because of the anticipated diagnosis of CVD and 
related procedural complications (Beckerman, Grossman, & Marquez, 1995; Davis, 
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Maguire, Haraphongse, & Schaumberger, 1994).  CVD includes coronary artery disease 
(CAD) or cardiac arrhythmias, a life-threatening illness, which needs immediate 
treatment and/or life-style changes (Gallagher, Trotter, & Donoghue, 2010).  Therefore, 
Csuhospital admission for these cardiac procedures to diagnose and/or treat CVD is 
stressful and anxiety provoking in many patients.  Patients waiting for cardiac procedures 
in an outpatient preprocedural unit may experience cardiac anxiety (CA), state anxiety 
(SA), and/or trait anxiety (TA).  These types of anxieties require different interventions.   
Moreover, anxiety is not assessed routinely in patients waiting for cardiac procedures in 
an outpatient, preprocedural unit.   
 Screening for at-risk individuals is often restricted to events and is often not 
captured as the evolving problem of anxiety.  It is important to identify the type of 
anxiety and offer appropriate treatment at the earliest time to prevent anxiety related 
adverse outcomes.  The long-term goal of this study is to develop effective screening and 
treatment procedures for specific preprocedural anxiety.   
 The objective of this particular study is to address the gap in evaluating the level 
of the preprocedural anxiety which includes cardiac anxiety, state anxiety, and trait 
anxiety in male and female patients admitted for elective cardiac procedures in a 
hospital-based outpatient, preprocedural unit. 
1.1 Statement of Purpose 
 The purpose of this study is to determine the difference in CA, SA, and TA in 
male and female patients admitted for invasive cardiac procedures in a hospital-based, 
preprocedural unit so that the specific anxiety can be identified and properly treated and 
managed.  Based on the literature review, the central hypothesis is that female patients 
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admitted for undergoing outpatient invasive cardiac procedures could experience higher 
level of preprocedural anxiety (CA, SA, and TA) than male patients undergoing 
outpatient invasive cardiac procedures, and patients with history of heart disease and 
hypertension could experience high level of CA and SA.  
1.2 Specific Aims and Research Hypothesis 
The specific aims of this study were four-fold:  
Aim 1: Determine differences in levels of cardiac anxiety, state anxiety, and trait anxiety 
between male and female patients undergoing an outpatient cardiac procedure after 
controlling for previous history of an outpatient cardiac procedure. 
The working hypotheses is that compared to males, female patients undergoing outpatient 
invasive cardiac procedures experience higher levels of cardiac anxiety, state anxiety, and 
trait anxiety. 
Aim 2: Determine the differences in cardiac anxiety, state anxiety, and trait anxiety 
between patients with and without history of heart disease and hypertension admitted for 
elective invasive cardiac procedures in an outpatient preprocedural unit after controlling 
for a previous history of an outpatient cardiac procedure. 
The working hypothesis is that patients with a history of heart disease and hypertension 
could have higher levels of cardiac anxiety, state anxiety, and trait anxiety compared to 
those with no history of heart disease and hypertension. 
Aim 3: Analyze the association among cardiac anxiety, state anxiety, and trait anxiety in 
patients admitted for elective invasive cardiac procedures in an outpatient preprocedural 
unit.  
 4 
The working hypothesis is that there could be a significantly strong positive correlation 
among cardiac anxiety, state anxiety, and trait anxiety in patients admitted for elective 
invasive cardiac procedures in an outpatient preprocedural unit. 
Aim 4: Determine what health factors and socio-demographic variables best predict 
cardiac anxiety, state anxiety, and trait anxiety in patients admitted for elective invasive 
cardiac procedures in an outpatient preprocedural unit. 
The working hypothesis is that health factors such as history of cardiac and 
electrophysiology (EP) procedure, heart disease, hypertension (HTN), smoking, 
depression, use of alcohol and recreational drugs, and socio-demographic factors such as 
education, age, and annual income could predict the level of cardiac anxiety, state 
anxiety, and trait anxiety in patients admitted for elective invasive cardiac procedures in 
an outpatient preprocedural unit. 
 The research team from Drexel University was well positioned to conduct the 
study.   The principal investigator is a Certified Adult Nurse Practitioner (APN-BC) and 
doctoral candidate with over nine years of clinical experience in cardiology.  Part of her 
doctoral education included a clinical practicum focusing on the assessment of anxiety in 
patients awaiting cardiac transplant, coronary artery bypass grafting, and coronary 
angiography with John Walter Covington Entwistle III, MD, PhD and Ralph J. Petrucci, 
Ed.D in an urban university hospital.  The co-investigator and supervising professor has 
been H. Michael Dreher, PhD, RN, FAAN Associate Professor, whose clinical 
background is in cardiovascular nursing; he is the first nurse to complete the jointly 
funded NIH, NHLBI, and NINR two-year postdoctoral research fellowship in sleep and 
respiratory neurobiology at the University of Pennsylvania.  The team also included Alice 
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Poyss PhD, MSN, Associate Clinical Professor at the Drexel college of nursing, whose 
research interests include nursing intervention and nursing treatment/outcome studies; 
Christine Maguth Nezu, PhD, ABPP, Professor of Psychology and Medicine in the 
Department of Psychology in the Drexel College of Arts and Sciences, who has 
conducted applied research in the area of clinical psychology and behavioral medicine.  
She is board-certified in cognitive and behavioral psychology with a research focus on 
developing empirically supported treatments for individuals with depression, various 
medical disorders such as cancer patients and persons with cardiovascular disease, 
personality disorders, and special populations; and Katie Featherstone, PhD, Senior 
Lecturer at Cardiff University, UK who is an expert in the sociology of biomedical 
knowledge and who currently works with a collaborating team to improve the diagnosis 
and management of angina. 
 The Cardiac Anxiety Questionnaire (CAQ) and Spielberger's State-Trait Anxiety 
Inventory Form–Y (STAI-Y) were used in this cross-sectional research design.  This 
study was particularly innovative, because it studied CA, SA, and TA independently in an 
outpatient, cardiac preprocedural unit.  Neither anxiety nor its specific types have been 
routinely assessed despite the increased prevalence of anxiety disorder in cardiology and 
the disproportionate utilization of medical resources and funding in treating patients with 
anxiety related symptoms.  
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1.3 Conceptual and Theoretical Framework 
The Concept of Anxiety. 
Anxiety is  
“a multidimensional emotional state manifested as a somatic, experiential, and 
interpersonal phenomenon; a feeling of uneasiness, apprehension, or dread.  
These feelings may be accompanied by symptoms such as breathlessness, a 
choking sensation, palpitations, restlessness, muscular tension, tightness in the 
chest, giddiness, trembling, and flushing, which are produced by the action of the 
autonomic nervous system, especially the sympathetic part of it” (O’Toole, 2003, 
p.82).    
Anxiety is a detrimental emotion that arises in response to perceived threats, from 
either internal or external source, which can be real or imagined.  Anxiety characteristics 
include inability to predict, control, or gain the desired results (Moser, 2007), and it has 
both functionally appropriate and inappropriate consequences.  Anxiety is appropriate or 
adaptive when it triggers coping responses that protect an individual from threats.  It 
becomes inappropriate or maladaptive when it increases or persists to a period that result 
in medical or psychological consequences and influences the individual’s everyday life 
(Whitley, 1992).  Patients with anxiety are at increased risk for acute cardiac events and 
in-hospital complications after admission for acute coronary syndrome or a cardiac 
procedure (Moser, 2007).  As strongly supported by decades of neuroscientific and 
learning research, anxiety reactions occurs as a result of higher-order conditioning of the 
autonomic nervous system to certain environmental events and situations.  Higher-order 
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conditioning is a process of associative learning that occurs when a previously 
conditioned stimulus is paired with a new conditioned stimulus (C. Nezu, Martell, & A. 
Nezu; in press). However, multidimensional anxiety theory (MAT) establishes a linear 
relation between anxiety and symptoms (Mackenzie, 2010).  Using MAT, we can predict 
that an increase in anxiety could have a negative effect on hemodynamics, performance, 
and quality of life.  Anxiety in patients with CVD increases sympathetic nervous system 
response which escalates anxiety symptoms that affect the physical, emotional, and 
psychological wellbeing of the person.    
The Conceptual Definitions of Anxiety. 
In psychology, anxiety is defined conceptually as,  
“the emotional component of biological responses to imagined danger, 
linked to intrapsychic conflict, clinical-physical tachycardia, dyspnea, trembling, 
cognitive difficulties, hypersensitivity, dizziness, weakness, dysarrhythmia, 
sweating, fatigue clinical-mental sense of impending doom, powerlessness; it is 
pathological when it interferes with effectiveness in living, achieving of goals or 
satisfaction, or reasonable emotional comfort” (“Anxiety,” n.d.,  para. 26). 
In psychiatry, anxiety is defined as, “a state of apprehension, uncertainty, and fear 
resulting from the anticipation of a realistic or fantasized threatening event or situation, 
often impairing physical and psychological functioning” (“Anxiety,” para. 1; McCance & 
Huether, 2002).  
 Craighead and Nemeroff (2004) defined anxiety is an emotion and state of mind 
characterized by aversive cognitive (apprehensive expectation of negative experience or 
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consequences), physiologic (autonomic hyperarousal with multiple somatic symptoms), 
and behavioral (hypervigilance, avoidance, paralysis of action) components (p. 70). 
 The following independent variables measured in this study include: 
Cardiac Anxiety (CA), State Anxiety (SA), and Trait Anxiety (TA).  Excluded groups: In 
this study individuals were excluded based on screening for frailty and dementia.  Those 
individuals who were deemed frail or were diagnosed with or currently been treated for 
dementia was excluded from the study. 
1.4 Theoretical and Operational Definitions   
Cardiac Anxiety (CA). 
 Cardiac anxiety is theoretically defined as a specific fear of cardiac-related stimuli 
and sensations because of their expected negative consequences (Eifert, 1992).  Cardiac 
anxiety is characterized by fear, worry, and uncertainty about chest and heart sensations, 
avoidance of activities believed to elicit cardiac symptoms, and heart-focused attention 
and monitoring of cardiac activity (Zvolensky & Forsyth, 2002).  Cardiac anxiety is 
commonly seen in both psychological and physical disorders (Eifert, 1992; Eifert, 
Zvolensky, & Lejuez, 2000).  
 Cardiac anxiety  is operationally defined by the score on the CAQ,  an 18-item 
self-report inventory scored on a five-point Likert scale, responses ranging from 0 (never) 
to 4 (always).  Higher scores indicate greater cardiac anxiety (Eifert & Thompson et al., 
2000). 
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State Anxiety (SA). 
 Spielberger (1972) defined state anxiety as “a transient experience of an 
unpleasant sensation that arouses worry and discomfort and is caused by intrinsic and 
extrinsic stimulation” (p. 29).  State anxiety reflects a "transitory emotional state or 
condition of the human organism that is characterized by subjective, consciously 
perceived feelings of tension and apprehension, and heightened autonomic nervous 
system activity" (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983,  p. 1).  
Trait Anxiety (TA). 
 Trait anxiety is theoretically defined as "relatively stable individual differences in 
anxiety proneness as a personality trait, that is, in the tendency to perceive and respond to 
stressful situations with elevations in the intensity of state anxiety (S-Anxiety) reactions” 
(Spielberger et al., 1983, p.1).  It refers to a general tendency to respond with anxiety to 
perceived threats in the environment (Fountoulakis et al., 2006, Spielberger et al., 1983). 
 State and Trait Anxiety is operationally defined by the scores on Spielberger 
State-Trait Anxiety Inventory (STAI) which consists of two 20-item self-report scales 
(Heikkila, Paunonen, Virtanen, & Laippala, 1998; Koivula, Paunonen, Tarkka, Tarkka, & 
Laippala, 2001).  Higher scores on the self-report questionaire obtained by sum of the 
ratings (range 20–80 on both scales) could indicate a greater anxiety and lower score 
indicating less anxiety (Spielberger, Gorsuch, & Lushene, 1970; Szekely et al., 2007).  
The cut point used to detect both state and trait anxiety was 40. 
Preprocedural Anxiety. 
Similar top preoperational anxiety, preprocedural anxiety can also be described as 
an unpleasant state of tension or uneasiness that results from a patient's doubts or fears 
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(from a vast array) before an operation (Pritchard, 2009). Preprocedural anxiety 
characteristics mainly include four criteria: 1) presence of vague, uneasy feeling of 
discomfort; 2) an unknown origin of anxiety; 3) a subjective response; and 4) an 
objective sign (Whitley, 1992).  Patients undergoing coronary angiography experience: 
loss of control of physical and personal self; an increased fear of the unknown; 
loneliness; fear of complication during and after the test; uncertainty of the outcomes that 
might affect their future; and insecurity due to lack of knowledge about the competency 
of the caregiver (Beckerman, Grossman, & Marquez, 1995).   
Frailty. 
 Frailty is theoretically defined as “a clinical syndrome in which three or more of 
the following criteria are present: unintentional weight loss (10 lbs. in past year), self-
reported exhaustion, weakness (grip strength), slow walking speed, and 
low physical activity” (Fried et al., 2001; p. 146).  Fried and his colleagues (2001) refer 
to frailty as a wasting syndrome, with weight loss and negative energy balance as 
important elements (p. 146-154).  It is also referred to as “physical disability, impairment 
in basic or instrumental activities of daily living, or simply an increased vulnerability to 
adverse outcomes” (Hogan, Macknight, & Bergman, 2003).  
 The operational definition of frailty is typically rules-based.  For the purpose of 
this study, Frailty was operationally defined based on data from the Cardiovascular 
Health Study Measure as inclusion of three or more of the following: weight loss, 
weakness, exhaustion, low activity level, or slow gait speed (Fried et al., 2001).  In this 
study, participants were considered frail if they had a diagnosis of congestive heart failure 
and five other chronic debilitating health conditions (e.g., myocardial infarction, angina, 
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diabetes, peripheral vascular disease, high blood pressure, cancer, chronic obstructive 
pulmonary disease (COPD), stroke, kidney failure/dialysis, arthritis, and any other major 
health conditions).  Also, if participants who have had any three criteria from the 
following which includes fatigue or dependency on others for activities of daily living, a 
lot of difficulty or inability to perform activities of daily life due to health or a physical 
condition, and/or unintentional weight loss of more than 10 lbs. in the prior year were 
considered frail (Pel-Littel, Schuurmans, Emmelot-Vonk, & Verhaar, 2009; Rockwood, 
Fox, Stolee, Robertson, & Beattie, 1994).  Patients who were deemed frail were excluded 
from the study.   
Dementia. 
 Theoretically dementia is defined in DSM-IV-TR as “the development of multiple 
cognitive deficits that include memory impairment and at least one of the following 
cognitive disturbances: aphasia, apraxia, agnosia, or a disturbance in executive 
functioning.  In addition, the cognitive impairments must be severe enough to cause 
impairment in social and occupational functioning and must represent a decline from a 
previously higher level of functioning” (APA, 2000, p. 148).  
 In this study, the operational definition of dementia was answering yes to a 
question asking if the patient was diagnosed with or had currently been treated for 
dementia.  The participants who answered yes to the question were excluded from the 
study.  Any participant with obvious signs of dementia before the study commenced or 
during questioning was eliminated.  
 12 
 
1.5 Chapter Summary 
 Anxiety is an independent risk factor for CVD, however the diagnosis of CVD 
unconventionally provokes anxiety in patients as it is associated with life-threatening 
events.  Therefore, when individuals get admitted to hospital for invasive cardiac 
procedures for diagnosis or treatment, they may experience multidimensional anxiety 
(CA, SA, TA) in the preprocedural unit; hospital admission for invasive cardiac 
procedures are stressful and produce anxiety in anticipation of related procedural 
complications.  Higher-order conditioning of the autonomic nervous system explains the 
development of anxiety in the preprocedural unit when individuals are admitted for 
invasive cardiac procedure. However, the multidimensional anxiety theory is used to 
establish a linear relation between anxiety and symptom which predicts that an increase 
in anxiety could have a negative effect on patient’s condition before and after procedure.  
Since anxiety in its different aspects requires different treatment, early detection of the 
type and level of anxiety could enable clinicians to tailor specific, individual-based 
treatment approaches.  This study has endeavored to seek the most prevalent type of 
anxiety in outpatient preprocedural unit.  The findings from this study can be used to 
increase clinicians’ awareness of the predominant type of anxiety which can guide them 
in their decisions about appropriate treatment for anxiety and prevent pre- and 
postprocedural anxiety related complications. 
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2. BACKGROUND AND SIGNIFICANCE 
2.1 Review of the Literature 
 This chapter reviews the relevant literature focusing mainly on CVD, anxiety, 
preprocedural unit anxiety, impact of anxiety on CVD and cardiac procedures, HTN and 
anxiety, and gender and age differences in CVD and anxiety.  This literature review 
provides the conceptual and theoretical framework which explains the concept of anxiety 
and connects the multidimensional constructs (SA, TA, and CA).  
2.2 What is Cardiovascular Disease 
 CVD is a major cause of disability and lost productivity in adults (Avendano et 
al., 2006).  CVD is the leading cause of death in the U.S and worldwide, thus it is 
considered a major public health problem (Natarajan, Gafni, & Yusuf, 2005; Thom et al., 
2006).  By 2030, 40.5% of the U.S. population is projected to have some form of CVD 
(Heidenreich et al., 2011).  In 2008, CVD accounted for 17.3 million deaths, and by 
2030, it is projected to be 23.6 million (World Health Organization [WHO], 2011).  The 
economic cost of CVD in the U.S. in 2006 including direct and indirect costs related to 
healthcare spending and loss of productivity from morbidity and mortality exceeded over 
$400 billion (Thom et al.).  The total direct costs are projected to increase by 61%, from 
$273 billion to $818 billion and indirect costs from $172 to $276 billion between 2010 
and 2030 (Heidenreich et al.).   
 In cardiology, the total number of inpatient cardiovascular operations and 
procedures has increased by 27%, from 5,382,000 in 1997 to 6,846,000 in 2007 (Roger et 
al., 2011).  Each year about 4.6 million people receive emergency medical services for 
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symptoms indicative of CVD (Burt, 1999).  Of these individuals, only one-quarter of 
them have true cardiac disease related symptoms, and the other three quarters of 
symptoms are likely noncardiac including CA or heart focused anxiety (Pope, Ruthazer, 
Beshansky, Griffith, & Selker, 1998).   
2.3 Why Study Patients Undergoing Invasive Cardiovascular Procedures 
 Patients undergoing invasive cardiovascular procedures experience high levels of 
anxiety (SA, TA, and CA) which exemplify the complexity of psychosomatic and 
physiological effects that influence the outcome of the procedures and the treatment and 
prognosis of CVD.   In cardiology, cardiac catheterization (CATH) with percutaneous 
intervention (PCI) and electrophysiological (EP) studies are the gold standard invasive 
procedures used for CVD diagnosis and treatment including life threatening coronary 
artery disease and cardiac arrhythmias (Bosen & Flemming, 2003; Caldwell, Arthur, 
Natarajan, & Anand, 2007; DeJong & Morton, 1997; Natarajan et al., 2005).  Hospital 
admissions for these invasive cardiac procedures are stressful and produce anxiety in 
many patients (Beckerman et al., 1995; Davis et al., 1994).  Furthermore, those with 
progressive CVD experience high degrees of anxiety before and after every cardiac 
procedure (Gulanick, Bliley, Perino, & Keough, 1998; Heikkila et al., 1998; Ryan, 1975; 
Trotter, Gallagher, & Donoghue, 2010), although they are unlikely to have a clinical 
diagnosis of general anxiety disorder.  However, little consideration has been given to the 
diagnosis and treatment of this problem.  Studies have reported that healthy 
psychological functioning or emotional vitality (sense of energy, positive well-being, and 
effective emotional regulation) reduce risk and the threat of cardiovascular events 
(Giltay, Geleijnse, Zitman, Hoekstra, & Schouten, 2004; Giltay, Kamphuis, Kalmijn, 
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Zitman, & Kromhout, 2006; Kubzansky, Sparrow, Vokonas, & Kawachi, 2001; 
Kubzansky & Thurston, 2007).   This effect is induced by the lowering of the heart rate, 
low blood cortisol level, low blood pressure, and attenuated fibrinogen stress response 
(Steptoe & Wardle, 2005; Steptoe, Wardle, & Marmot, 2005b).  Thus, it is important to 
study the effect of anxiety, especially CA, on cardiovascular outcomes. 
2.4 Impact of Anxiety on CVD and Cardiac Procedures 
 Anxiety is an independent risk factor of CVD, and it is associated with increased 
cardiac morbidity and mortality (Levenson, 2006; McCann, Fauerbach, & Thombs, 2005; 
Sheps & Sheffield, 2001).  The prevalence of anxiety disorders in cardiology clinics 
ranges between 25% and 35% (Eifert, Zvolensky, & Lejuez, 2000; Fleet & Beitman, 
1998).  Individuals with cardiac diseases or cardiac symptoms experience elevated health 
related anxiety (Aikens, Michael, Levin, & Lowry, 1999) which increases sympathetic 
nervous system response, resulting in an increase in heart rate, respiratory rate, and blood 
pressure.  Studies have reported that patients who exhibit these physiological symptom 
variations, especially heart rate variation due to high levels of anxiety, have a 4.5 – 6.0 
fold increase in risk for sudden cardiac death (Albert et al., 2005; Kawachi, Sparrow, 
Vokonas, & Weiss, 1994; Kawachi, Sparrow, Vokonas, & Weiss, 1995; Watkins, 
Grossman, Krishnan, & Sherwood, 1998).  High levels of stress and anxiety also leave 
men at a 50% higher risk of sustaining myocardial infarction (Rosengren, Tibblin, & 
Wilhelmsen, 1991).  Williams and colleagues (2013) reported in a recent study that high 
level of anxiety in patients anticipating cardiac procedures is a strong and independent 
predictor of mortality and morbidity.  Preoperative high level of anxiety is also associated 
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with increased discharge to a healthcare facility like a nursing home, convalescence, or 
rehabilitation facility. 
 Cardiac preprocedural unit anxiety may increase a patient’s feelings of uneasiness 
in the unfamiliar surroundings (Dirik & Karanci, 2003).  High level of anxiety over 
sensitize the patient to unpleasant stimuli which heighten their senses of touch, smell, or 
hearing resulting in intense pain, dizziness, and nausea.  These preprocedural 
physiological and psychological responses to the stressors increase the duration of 
invasive procedures, need for sedatives, analgesics, and anesthetic requirements (Nilsson, 
Lindell, Eriksson, & Kellerth, 2009).  Patients also experience intensified postoperative 
pain and may even have a prolonged hospital stay (Agarwal et al., 2005).  Studies have 
revealed that patients with high preprocedural anxiety before surgical cardiac procedures, 
such as coronary artery bypass surgery and valve surgery, had increased postoperative 
complications (Stengrevics, Sirois, Schwartz, Friedman, & Domar, 1996), increased 
hospitalizations for cardiac symptoms (Szekely et al., 2007), increased mortality risk 
(Tully et al., 2011), and  increased chest pain and poorer outcomes (Gallagher et al., 
2010).  On the contrary, patients with low levels of anxiety had fewer complications 
postprocedure and had better quality of life postoperatively (Tung, Hunter, Wei, & 
Chang, 2009).  Studies have also found that despite detailed explanation during the 
informed consent process, before any invasive cardiac procedure, patients have their own 
concerns related to the risks associated with the procedure and their own perception of 
risk and anticipation of diagnostic confirmation and its related complications (Heikkila  
et al., 1998), which may even lead to cancellation of the procedure (Caldwell et al., 
2007). 
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2.5 Anxiety in Preprocedural Unit: State, Trait, and Cardiac Anxiety  
 Anxiety disorder (AD) is the most common psychiatric illness in the U.S affecting 
40 million adults, ages 18 and older (Anxiety Disorder Association of America [ADAA], 
2010-2011); Kubzansky, Kawachi, Weiss, & Sparrow, 1998).  In 2003, AD was found to 
be the second leading cause of the burden of disease after ischemic heart disease (Smith, 
2007).  It impose great personal, economic and societal burden (Alexander et a., 2007; 
Katzman, 2009; Ninan, 2001).  AD costs more than $42 billion a year, almost a third of 
the country's $148 billion total mental health bill (ADAA, 2010-2011); Greenberg et al., 
1999).  Over half of the total $42 billion is associated with the repeated use of health care 
services (ADAA, 2010-2011) especially by patients whose anxiety symptoms mimic 
physical illnesses (Baldwin, Ajel, & Garner, 2008).  Studies have shown that AD is often 
associated with other psychiatric illness such as major depressive disorder, psychosis, 
mania, and substance abuse disorder and non-psychiatric disorders such as 
hyperthyroidism, Cushing’s disease and mitral value prolapse (Alexander et al., 2007; 
Katzman, 2009; Ninan, 2001). 
 In individuals hospitalized for elective invasive CATH and EP procedures, 
preprocedural anxiety is elicited in anticipation of real or imagined future events, loss of 
control, fear of discomfort, uncertainty, fear about survival, or suffering from some life 
threatening heart disease (cardiophobia) (Trotter et al., 2010;  White, 2008).  Findings 
from qualitative studies report that preprocedural concerns are more distressing than 
chest pain requiring urgent hospitalization (Frasure-Smith et al., 1995; Grunberg et al., 
2003; Higgins, Dunn, & Theobald, 2000; Lunden, Bengston, & Lundgren, 2006).   
Anxiety in these patients has two closely related dimensions: 1) state, a transient 
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experience; and 2) trait, an enduring and predictable behavioral response (Spielberger et 
al., 1983; Uzun, Vural, Uzun, & Yokusoglu, 2008).   
 State anxiety (SA) is "a transient experience of an unpleasant sensation that 
arouses worry and discomfort and is caused by intrinsic and extrinsic stimulation" 
(Spielberger, 1972, p. 29).  SA in these patients is likely due to discomfort, unfamiliarity 
with strange environments, uncertainty about the findings of the procedure, potential 
influence of the cardiac diagnosis and illness on their occupations, personal lives, 
relationships with others, and fear of death (Higgins et al., 2000; Higgins, Dunn, & 
Theobald, 2001; White & Frasure-Smith, 1995).   
 Trait anxiety (TA) refers to "relatively stable individual differences in anxiety 
proneness, that is, the tendency to perceive and respond to stressful situations with 
elevations in the intensity of state anxiety reactions” (Spielberger et al, 1983, p.1).  Since 
a patient with a stronger anxiety trait could experience intense levels of SA (Spielberger, 
1983), patients in preprocedural unit who have TA could experience high level of SA 
from the anticipation of real or imagined future events, loss of control, fear of discomfort, 
uncertainty, fear about survival, or suffering from some life threatening heart disease or 
cardiophobia (White, 2008).  These preprocedural concerns have been reported by many 
qualitative studies to be more distressing than chest pain requiring urgent hospitalization 
(Higgins et al., 2000; Frasure-Smith et al., 1995; Grunberg et al., 2003; Lunden et al., 
2006).  
Individuals waiting for cardiac procedures in preprocedural units may also 
experience high levels of cardiac anxiety (CA) which is exclusively associated with the 
fear of cardiac-related stimuli and sensations based upon their perceived negative 
 19 
consequences (Eifert, Thompson, & et al., 2000; see Figure 5).  Patients with CA 
experience distress because of the belief that cardiac disease related symptoms, especially 
chest pain, are indicative of a pathological cardiac functioning (Aikens, Michael, Levin, 
& Lowry, 1999; Carter et al., 1992; Krantz & McCeney, 2002).  The anxiety 
characteristics persist for years or even decades, and relatively few remit spontaneously 
or without treatment (U.S. Department of Health and Human Services [USDHHS], 
1999).  These individuals are attentive to cardiac-congruent sensations due to the public 
perception that cardiac related symptoms are dangerous (Eifert, Zvolensky, et al. 2000).  
However, Cox (1996) identified that these specific salient fears cue trigger anxiety in 
individuals with and without heart disease.  Exclusively in preprocedural unit, the 
anticipation of diagnostic confirmation of cardiac disease and its related complications 
that disrupt personal, family, and social life, of making life style changes, and the 
associated heart related complications and life threatening events could elicit negative 
physiological changes requiring urgent intervention. 
In both cardiac and noncardiac patients, CA is the key factor in producing 
cardiopulmonary and psychological distress, which is associated with a number of 
clinical and medical syndromes (Eifert, 1992; Eifert, Hodson, Tracy, Seville, & 
Gunawardane, 1996).  Although CA is not related to bodily sensations, it is specific to 
cardiac related events and events perceived to be related to cardiac causes.  CA is 
clinically relevant as symptoms of CA predict quality of life.  That is, high levels of CA 
adversely influence recovery and adherence to suggested behavior and lifestyle changes 
that are intended to reduce coronary risk (Emery, Frid, Glazer & Banyasz, 2002; 
Zigelstein et al., 2000), participation in cardiac rehabilitation (Glazer, Emery, Frid, &  
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Banyasz, 2002), and return to employment (Soderman, Lisspers, & Sundin, 2003).  And 
finally, CA increases cardiac mortality and morbidity (Frasure-Smith et al., 1995; Krantz 
& McCeney, 2002).  Since CA is more specific than other psychological factors linked to 
development and maintenance of anxiety problems, it can be defined as a subset of 
anxiety sensitivity, which is described as fear of anxiety related symptoms in general, 
based on the belief that they have harmful consequences (Reiss & McNally, 1985).  
Certainly in patients with CA, the fears and worries about dying and/or having a heart 
attack induce worry or fear about chest pain symptoms.  As a result, these individuals 
anxiously monitor their heart and pulse, avoid activities that bring on the symptoms, and 
repeatedly seek reassurance from healthcare providers (Eifert, Thompson, & et al., 2000).   
Preprocedural anxiety (SA, TA, or CA or combinations of these) in those 
individuals who are awaiting cardiac procedure may cluster around adaptive and 
maladaptive presentations.   An adaptive response to anxiety may aid in the preparation 
for procedure; however, a negative or maladaptive response can cause harm (Pritchard, 
2009).   
 In cardiology, CA is often misdiagnosed or unrecognized as a primary problem 
that contributes to the presenting symptoms (Fleet & Beitman, 1998).  As is widely 
known, CA is predictive of disability due to its persistent nature, as persistent anxiety 
increases physical signs and symptoms and deteriorates functional status (Sullivan, 
LaCroix, Baum, & Grothaus, 1997; Sullivan, LaCroix, Spertus, & Hecht, 2000).  Studies 
have shown that in patients with CVD, anxiety, particularly CA, provoke and intensify 
the severity and frequency of chest pain and may likely increase the probability of 
cardiovascular death (Fleet & Beitman, 1998; Mendels, Chernoff, & Blatt, 1986).   
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However, in patients without CVD, CA can result in costly doctor visits and medical 
examinations followed by renewed anxiety and worry (Aikens, Wagner, & Saelinger, 
1999). 
2.6 The Clinician’s Conundrum: Which Type of Anxiety Is It? 
 CA, SA, and TA contain psychological elements common to the categories of AD 
classified by Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision 
(DSM-IV-TR), such as hypochondriasis, panic disorder, specific phobias, and adjustment 
disorders (APA, 2000; Eifert, Zvolensky & et al., 2000).  CA and TA share 
characteristics of hypochondriasis and panic disorders characterized by prevalent health 
anxiety, illness beliefs (Hiller, Liebbrant, Rief, & Fitcher, 2005), recurrent unexpected 
panic attacks, and development of either a persistent fear of having future panic attacks, 
persistent worry about the implications of the attack or consequences, or significant 
changes in behavior related to the attacks (APA, 2000; Eifert, Zvolensky, & et al., 2000).  
Furthermore, the key feature of CA is similar to that of hypochondriasis, an abnormal 
concern that one is developing or has a serious illness based on misinterpretation of 
bodily symptoms; furthermore, the person is preoccupied with health concerns for at least 
six months despite appropriate medical evaluation and reassurance (Eifert, Zvolensky, & 
et al., 2000).  The clinical presentation of CA is more similar to hypochondriasis than 
panic disorder because of its distinguishable clinical condition characterized by more 
psychopathology, distress, and increased healthcare utilization (Hiller et al. 2005).  
However,  CA is analogous to panic attack  as in both there is a discrete period of intense 
fear or discomfort characterized by a display of various cardiopulmonary symptoms 
(APA, 2000).   
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 The features of CA and SA also concur with those of a specific phobia with 
“marked and persistent fear that is excessive or unreasonable cued by the presence or 
anticipation of a specific object or situation" (APA, 2000, p. 449).  CA and SA are 
similar to the two subtypes of specific phobias; CA is the specific fear phobia that relates 
to the fear of an explicit cause, and SA is the situational type of phobia that includes fear 
of situations.  SA and TA are nonpathological forms of transient anxiety which, along 
with the inherent nature of TA, manifests the characteristics of panic disorder (Arnold, 
Zai, & Richter, 2004; Gross & Hen, 2004; Kendler, Aggen, Jacobson, & Neale, 2003; 
Lau, Eley, & Stevenson, 2006; National Institute of Mental Health Genetics Workgroup 
[NIMHGW], 1998).  However, when a nonpathological transient anxiety (SA, TA) 
perpetuates itself over the long-term, it changes to persistent anxiety (CA) and becomes 
abnormally severe (Salkovskis, Warwick, & Deale, 2003).  Severe persistent pathological 
anxieties such as TA and CA are clinically important, because they are associated with 
impairment of physical, psychological, and hemodynamic functioning.  Persistent anxiety 
characteristics in TA and CA are manifested by symptoms of motor tension, autonomic 
hyperactivity, apprehension, and hyper-attentiveness (APA, 2000).  These pathological 
forms of persistent anxiety severely interfere with normal life (Gross & Hen, 2004), are 
predictive of disability (Sullivan et al., 1997; Sullivan et al., 2000), hinder adjustment to 
the disease condition and recovery after an acute event, increase risk for more cardiac 
events, and in patients with CVD, they either delay or prevent returning to work 
(Benninghoven et al., 2006, Moser, 2007). 
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Table 1  
Psychological Elements in Cardiac Anxiety, State Anxiety, and Trait Anxiety are Similar 
to Anxiety Disorder Classified by DSM-IV-TR 
 
Characteristics of CA Characteristics of SA Characteristics of TA 
Persistent, pathological 
Becomes abnormally severe 
Transient, nonpathological Transient, nonpathological 
Inherent 
Hypochondriasis & Panic Disorder 
 Prevalent health anxiety and 
Illness belief 
 Misinterpretation of bodily 
symptoms 
 Recurrent unexpected panic 
attacks- discrete intense fear 
manifested as cardiopulmonary 
symptoms 
 Persistent fear of future panic 
attacks 
 Persistent worry about the 
implications of the attack or 
consequences, or significant 
changes in behavior related to 
the attacks 
Key Feature of Hypochondriasis 
 Abnormal concern 
 Preoccupied with health 
concerns for at least six months 
 More psychopathology and 
distress 
 Increased healthcare utilization 
 Discrete period of intense fear or 
discomfort-similar to panic 
attack 
 Pathological/becomes 
abnormally severe 
 Increased healthcare use 
 Hypochondriasis & Panic 
Disorder 
 Prevalent health anxiety 
and Illness belief 
 Misinterpretation of 
bodily symptoms 
 Recurrent unexpected 
panic attacks- discrete 
intense fear manifested 
as cardiopulmonary 
symptoms 
 Persistent fear of future 
panic attacks 
 Persistent worry about 
the implications of the 
attack or consequences, 
or significant changes in 
behavior related to the 
attacks 
 Nonpathological & 
Inherent as panic 
disorder 
Specific Phobia 
 Excessive or unreasonable 
persistent fear 
 Fear of an explicit cause 
Specific Phobia 
 Excessive or 
unreasonable fear 
 Fear of situations 
Nonpathological transient 
anxiety (SA, TA) 
perpetuates itself over the 
long-term and changes to 
pathological persistent 
anxiety 
Note. Created by Shajimon, B. 2012 from - APA, 2000; Eifert, Zvolensky, & Lejuez, 
2000; Hiller et al., 2005. 
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 In the cardiac preprocedural unit, the thought of the negative consequence 
involved with the particular procedure or heart disease conviction following the 
procedure contributes to development of a specific fear.  Whereas, the individual's beliefs 
and interpretations about feared situations lead to the development of  preprocedural SA, 
and those beliefs related to cardiac specific life threatening disease conviction lead to CA.  
In the preprocedural unit, patients with TA could experience a high level of SA and 
perhaps CA also.  When referring to a specific phobia, especially in preprocedural, a 
patient with CA experiences feelings of anxiety, fear, or panic immediately upon 
encountering the feared situation.  The person avoids the feared object or situation or 
encounters the situation with intense anxiety causing significant distress.  This excessive 
or unreasonable anxiety interferes with physiological changes in the preprocedural unit 
and their day-to-day life, yet these symptoms are not recognized or diagnosed as specific 
phobia for at least six months especially in individuals under age 18 years and they are 
not accounted for as a mental disorder (APA, 2000; Eifert, Zvolensky, & Lejuez, 2000).  
Similar to the diagnosis of other medical disorders, the diagnosis of AD can be 
approached in a systematic way and can result in an appropriate intervention.  Since high 
levels of anxiety are potentially amendable, identifying these patients in preprocedural 
units or cardiology clinics would provide an opportunity to increase psychological well-
being, decrease risk, and improve the clinical outcome.    
2.7 Are There Gender and Age Differences in CVD and Anxiety 
 CVD is the single leading cause of death for both men and women (Center for 
Disease Control and Prevention [CDC], 2010).  There are significant differences in 
gender and age for those with CVD (Ho, Paultre, & Mosca, 2005).  An estimated 
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82,600,000 American adults (39.9 million men; 42.7 million women) or greater than 1 in 
3 have one or more types of CVD.  Almost half of them are estimated to be 60 years of 
age and older (Roger et al., 2011).  However, there are also differences in the ages of 
both men and women at which CVD is diagnosed.   In men, symptoms of CVD usually 
appear early in their fifties, whereas in women similar symptoms often do not show until 
they are in their sixties when they are often complicated by other health problems, such 
as diabetes, making effective treatment more difficult (Olsen, 2011; WHO, 2009).  In 
women, late onset of CVD symptoms to some extent is due to the estrogen protection in 
early life (Jousilahti, Vartiainen, Tuomilehto, & Puska, 1999).  As a result, CVD events 
occur 10 years later in life in women compared to men causing a higher mortality rate 
from CVD among women than in men (Roger et al., 2011).  Since 1984, in the U.S., the 
number of CVD deaths for women has exceeded those for men.  Ever since, the burden of 
heart disease on women and the global economy continues to increase (Yusuf, Reddy, 
Ounpuu, & Anand, 2001). In 2007, CVD accounted for 51.8% deaths in women and 
48.2% death in men (Roger et al., 2011).  Despite a high prevalence of CVD in women, 
disparity in screening, diagnosis, and treatment for CVD exists, which probably 
contributes towards increased heart related anxiety in women (Ayanian & Epstein, 1991).   
 In addition to gender differences, age also differs significantly in the prevalence 
of CVD.  According to 2007 statistics, those aged 65 and older had the highest rate of 
CVD.  It was also reported that the average annual rate of first cardiovascular event rise 
with increasing age from 3 per 1000 men at 35 to 44 years of age to 74 per 1000 men at 
85 to 94 years of age (Roger et al., 2011).  The gap narrows with advancing age.  The 
American Heart Association reported in 2007 that more than 150,000 Americans died as 
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a result of CVD were less than 65 years of age; nearly 33% who died were less than 75 
years of age, which is before the average life expectancy of 77.9 years (Roger et al., 
2011).  Since women are at high risk of having heart attacks at older ages than men, the 
death rate due to myocardial infarction is higher in women than in men (American Heart 
Association, 2007; Roger et al., 2011).  It was also found that approximately 26% of 
women aged 45 years of age or older die within a year compared to only 19% of men 
after an initially recognized myocardial infarction (Roger et al., 2011). 
 Anxiety disorder, specifically panic disorder, is the most common mental health 
problem affecting about 6 million American adults (Kessler, Chiu, Demler, & Walters, 
2005).  It is twice as common in women as in men (Alexander, Dennerstein, Kotz, & 
Richardson, 2007;  Katzman, 2009; Robins & Regier, 1999).  In AD an overall female to 
male ratio of 2:1 is seen across the age range of 18-65 (Smith, 2007; Wittchen & Jacobi, 
2005).  Younger women have a higher prevalence of AD than younger men, and this 
difference diminishes with increasing age (Krasucki, Howard, & Mann, 1998).  
Salzman's (1991) study found that AD is less prevalent in later life than in young adult 
life.  Similar results have been found in the data from a normative sample of working 
adults.  This data suggested that men and women over age of 50, especially women, have 
lower levels of SA and TA than younger men and women, and the youngest group of 
women have substantially higher anxiety than any other group (Spielberger et al., 1983).  
Lau and colleagues (2006) found that women have high levels of TA.    
 Anxiety is a major problem for younger patients (Krasucki et al., 1998).  It is also 
a common problem for older patients because of the presence of comorbid chronic illness 
such as HTN, depression, COPD, irritable bowel syndrome, or diabetes (Smith, 2007).  
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However, when compared to gender differences, result of the studies done by Gallagher 
and colleagues (2010) and Heikkila and colleagues (1998) have demonstrated that 
women (especially with CVD) compared to men experience more psychological stress 
that produces anxiety related to the fear of the outcome of the CATH procedure (p = 
.0001), possible bypass surgery (p < .0001), pain (p = .004), job strain, vital exhaustion, 
social isolation, lack of social support (p = .009), potential sexual difficulties, hostility 
and anger, anxiety and depression, diagnosis of CVD, and some fear of death (p = .041; 
Gallagher et al., 2010; Heikkila et al., 1998).  Furthermore, since women have an 
increased anxiety, from the fear of pain, their chest pain symptoms often continued after 
CATH procedures (Heikkila, Paunonen, Virtanen, & Laippala, 1999).   
2.8 Hypertension and Anxiety 
HTN is a biological mediator in the causal pathway of coronary heart disease 
(Albert et al., 2005).  Patients with HTN are at increased risk for CVD (Gerund, Aiken, 
West, & Erchull, 2004).  Studies have reported that individuals with a diagnosis of HTN 
consider high blood pressure as to be a serious medical condition and perceive 
themselves as being sick (Melamed, Froom, & Green, 1997; Spruill et al., 2007).  Their 
response to this health threat has a significant effect on their emotional state which 
influences physiological regulation and psychological dysfunction ((Rostrup & Ekeberg, 
1992).  A large study done in South Africa (N =4351) provided evidence of an 
association between HTN and anxiety disorders (Grimsrud, Stein, Seedat, Couldiams, & 
Myer 2009).  It is also reported that anxiety levels in middle aged men and women are 
predictive of the incidence of HTN (Jonas, Franks, & Ingram, 1997; Markowitz, 
Matthews, Kannel, Cobb, & D’Agostino, 1993).  HTN diagnosis along with another 
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chronic physical condition was associated with 12 months of anxiety disorders (Grimsrud 
et al., 2009).  In addition, a study by Jhalani and colleagues (2005) provided empirical 
support that anxiety and blood pressure expectancy elevate clinical blood pressure, which 
may be associated with cardiovascular disease and future cardiac events. 
  HTN status, which has either been diagnosed or labeled HTN, has a significant 
effect on SA during a clinical visit independent of true hypertensive status.  The patients 
were found to have higher level of SA in a clinical setting compared to those who were 
unaware or had never been diagnosed with HTN according to the results of the study 
done by Rostrup and Ekeberg (1992) and Spruill et al., (2007).  A prospective study by 
Albert and colleagues (2005) reported that patients without baseline CVD, but who have 
the factors like HTN, experience a high level of phobic anxiety that increased their risk 
for sudden cardiac death and fatal coronary heart disease.  However, anxiety was found 
not only to affect the myocardium, but also led to HTN, as the chronically increased 
catecholamine levels associated with anxiety has been shown to elevate blood pressure 
(Jonas et al., 1997).  Studies have indicated that individuals with anxiety disorder have a 
higher incidence of HTN, and evidence indicated that TA was a predictor of a subsequent 
rise in blood pressure (Jenkins, Sooervell, & Hames, 1983; Markowitz, Matthews, Wing, 
Kuller, & Meilahn, 1991; Pernini, Muller, & Buhler, 1991).  Studies have also suggested 
that anxiety levels in middle aged men and women are predictive of the incidence of 
HTN (Markowitz et al., 1993; Jonas et al., 1997).   
2.9 Conceptual and Theoretical Framework 
Anxiety is a detrimental emotion that arises in response to perceived threats, from 
either internal or external source, which can be real or imagined.  Anxiety characteristics 
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include inability to predict, control, or gain desired results (Moser, 2007).  Anxiety 
becomes inappropriate when it increases or persists to a level that could result in medical 
or psychological consequences and influence an individual’s everyday life (Whitley, 
1992).  
 Patients undergoing cardiac procedures experience mental conflict that give rise 
to anxiety that includes the feeling of helplessness, loss of control of the situation, 
uncertainty of procedure and future, anticipation of the risk and outcomes of the cardiac 
procedure, threat of CVD and death, having to make treatment choice for CVD, living 
with CVD, functional ability, quality of life, and influence on social life.  An increased 
level of anxiety is found to have a negative effect on hemodynamics, performance, and 
quality of life which is explicitly explained using Multidimensional anxiety theory 
(MAT; see Figure 4).  This theory established a linear relation between anxiety and 
symptoms (Mackenzie, 2010).  Using MAT, we can predict that an anxiety in patients 
with CVD would increase the sympathetic nervous system response which would 
escalate anxiety symptoms that would affect the physical, emotional, and psychological 
wellbeing of the person (Mackenzie, 2010; Morris, Davis, & Hutchings, 1981).  These 
theories are discussed in detail in chapter five. 
2.10 Chapter Summary 
 Despite advancement in technology, CVD remains the leading cause of death and 
disability in adults worldwide.  Since CVD is associated with high morbidity and 
mortality, the invasive cardiac procedures used for diagnosis of this life-threatening 
disease provoke anxiety (CA, SA, and TA) in patients.  In the preprocedural unit, where 
patients are waiting for invasive cardiac procedure, SA is due to the interaction between 
 30 
disposition and a stressor, and CA results from the interplay of genetic vulnerability to 
anxiety symptoms and the cardiac focused environment.  On the other hand, TA is a 
genetically mediated disposition toward anxiety.  Therefore, TA is manifested as SA 
under threatening circumstances and CA due to cardiac related symptoms, cardiac disease 
conviction, fear of CVD, and related mortality and morbidity.  The possible 
preprocedural anxiety (CA, SA, or TA) experienced by an individual is a 
multidimensional construct that can be transient or persistent in nature.   
 The purpose of the study is to determine the difference in CA, SA, and TA in 
male and female patients admitted for invasive cardiac procedures in a hospital-based, 
preprocedural unit so that the specific anxiety can be identified and properly treated and 
managed.  Persistent CA affects the patient physiologically and psychologically which 
prolongs hospital stay, increase procedural duration, increase anesthetic requirements, 
and increase postoperative pain.   Unlike transient anxiety (such as SA, TA, and panic 
disorder), persistent anxiety (such as CA, hypochondriasis) needs structured long-term 
behavioral therapy and medications.   Young women compared to young men suffer more 
from persistent anxiety.  These individuals need to be diagnosed earlier in life regardless 
of their medical status to tailor appropriate treatment.  Early diagnosis would help them 
cope with the disease, decrease complications, improve prognosis and quality of life, 
decreases their level of functional impairment, increase their quality of life, and reduce 
health care costs.  Therefore, the nursing profession needs to take the initiative to identify 
people’s psychological needs and provide appropriate care in collaboration with the 
medical team.  It is important to heighten awareness among nurse clinicians and scholars 
to fill the gap in current knowledge in this population so that individuals with CA, SA, 
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and TA can have a better quality of life which in turn can have positive individual and 
societal implications.  
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3. RESEARCH DESIGN AND METHODS 
 This chapter describes the research design and methods used in the study.  The 
methods descriptions include the process of sample selection and sample size estimation, 
a description on the instruments used, the protection of human subjects, risk and benefits, 
inclusion of women and minority subjects, inclusion of children, data and safety 
monitoring plan, procedure, compensation to subjects, benefit to society, vertebrate 
animals, timeline for the project, and the statistical methods used for data analysis. 
3.1 Research Design 
 A cross-sectional descriptive design was used to examine the differences in CA, 
SA, and TA in patients admitted for an invasive cardiac procedure in an outpatient 
preprocedural unit (see Figure 1). 
 
Figure 1: Research Design 
 
 
3.2 Sample and Subject Recruitment 
 A convenience sample of 92 patients who met the inclusion criteria were recruited 
from 113 consecutive patients admitted in an outpatient preprocedural unit for invasive 
cardiac procedure in a large urban university hospital.  The reason to recruit subjects 
from a large urban university hospital was to represent the target population adequately, 
and the reason to sample patients consecutively was to provide equal probability of 
selection to each patient.  Potential subjects were selected based on the following criteria.  
 33 
1. The potential subject was at least 30 years of age. 
2. The potential subject was scheduled for an elective invasive cardiac procedure. 
3. The potential subject was able to give informed consent. 
4. The potential subject was fluent in the English language. 
5. The potential subject was enrolled in the study for at least 1 hour before the 
 procedure was scheduled. 
The subjects were excluded from the sample based on the following criteria. 
1. The subject required emergency cardiac procedures. 
2. The subject did not speak or understand English. 
3. The subject was deemed as demented or frail. 
4. The subject was 89 years or older.    
3.3 Sample Size Estimation 
 A power analysis was conducted to determine the sample size necessary to test 
the hypotheses and thus minimize a Type II error.  The primary hypothesis was that there 
is a significant difference in CA scores using the CAQ-R survey by gender for patients 
undergoing elective cardiac procedures in an outpatient preprocedural unit.  It was 
hypothesized that CA scores in women would be significantly higher than those of men 
for this population.  Based on published studies in similar patient populations, the 
expected mean CAQ score for female patients was 1.3 with a standard deviation of 0.8 
and male patients was 0.8 with a standard deviation of 0.8 (Van den Broek, Nyklicek & 
Denollet, 2009).  An expected 60% of the sample was expected to be men and 40% 
would be women.  A sample of 48 male patients and 32 female patients were needed in 
order to achieve 80% power to detect a difference of 0.5 in the mean CAQ-R score 
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between female and male patients with a standard deviation of 0.8 (effect size of 0.63). 
The significance level was set at 5% using a two-sided t-test.  For a significance level of 
alpha 0.05 and to achieve a power of 0.80, a minimum sample of 80 subjects would be 
required.  An institutional review board approval was obtained for 125 to obtain the 
minimum number of 80. 
3.4 Instrumentation 
Three instruments were used for the measurement of study variables.  These were: 1) 
The Cardiac Anxiety Questionnaire-Revised (CAQ-R); 2) The Spielberger State-Trait 
Scale Form–Y (STAI-Y); and 3) Demographic Data Form. 
 The Cardiac Anxiety Questionnaire-Revised (CAQ-R).   
 The Cardiac Anxiety Questionnaire (CAQ) is designed to measure heart-focused 
anxiety or CA.  The revised version of this is CAQ-R (Eifert, Thompson, & et al., 2000; 
see Appendix B), which was used to measure the level of CA prior to cardiac procedures.  
The CAQ-R is an 18-item self-report inventory scored on a five-point Likert scale; 
responses range from 0 (never) to 4 (always).  Higher scores indicate greater CA (Eifert, 
Zvolensky, & et al., 2000).  Eifert, Thompson, and colleagues (2000) evaluated the CAQ 
in a sample of 188 participants undergoing outpatient coronary angiography.  It had been 
shown to be successful when used as a screening measure in clinical research Aikens, 
Michael, Levin, & Lowry, 1999; Van Etten, Abelson, Lowell, Schwartz, & Briggs, 1999) 
and as a cognitive behavioral therapy outcome measure with the medical population 
(Eifert, Zvolensky et al., 2000; Eifert & Lau, 2001; Esler et al., 1999; Van Etten et al., 
1999).  CAQ is composed of four subscales: 1) worry and fear (heart focused worry and 
fear), 2) avoidance behavior (avoidance of strenuous activities believed to elicit cardiac 
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symptoms –“cardioprotective behavior”), 3) attention (heart-focused attention and 
monitoring), and 4) safety seeking (safety and reassurance seeking behavior; Eifert, 1992; 
Marker, Carmin, & Ownby, 2008).  The CAQ-R yields a total score for each subscale and 
an average item score for each factor by calculating a sumscore across items and dividing 
by the number of items endorsed for each factor.  Furthermore, a total average score is 
calculated by summing across all items and dividing by 18.  Reliability analysis revealed 
good internal consistency of the total (Cronbach's alphas of 0.87) and four subscale 
scores (Cronbach's alphas of 0.81, 0.81, 0.69, and 0.70 respectively); item-scale 
correlations range between 0.30 and 0.77.  Inter-scale correlations range from 0.19 
(attention/safety) to 0.51 (worry/safety; Eifert, Thompson, & et al., 2000).  CAQ has also 
demonstrated a good convergent validity when correlated with the Anxiety Sensitivity 
index (Reiss, Peterson, Gursky, & McNally, 1986).  Factorial invariance across groups 
was assessed, which showed that the factor structure of the CAQ did not differ in 
individuals with or without clear evidence of coronary disease. 
The Spielberger State-Trait Anxiety Inventory Form–Y (STAI-Y).  
 The Spielberger State-Trait Anxiety Inventory (STAI) is a definitive self-report 
assessment instrument designed to measure and to differentiate between anxiety as a state 
and as a trait (Spielberger et al., 1970).  The newer version STAI Form-Y (Spielberger, 
1983; see Appendix B) was used to measure the level of state-trait anxiety prior to 
cardiac procedures.  The STAI-Y state and trait scale has 20 items each describing how 
people generally feel, rated on a four-point frequency scale from almost never to almost 
always.  The median alpha coefficient for Form-Y is 0.90 and 0.93, and test-retest 
coefficients range from 0.73 to 0.86 and 0.16 to 0.62 for scores on the TA and SA scales 
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respectively (Spielberger, 1983).  The STAI-Y has been used extensively, and construct 
validity, concurrent validity, and test-retest reliability have been established as adequate 
by using scores for medical and surgical patients, dental patients, high school and college 
students, military personnel, and psychiatric patients (Astin, Jones, & Thompson, 2005).  
Several studies have revealed adequate internal consistency and convergent validity in 
older adult population (Himmelfarb & Murrell, 1983; Iwata et al., 2000; Kabacoff., 
Segal, Hersen, & Hasselt, 1997; Kvaal, Laake, & Engedal, 2001; Kvaal, Ulstein, 
Nordhus, & Engedal, 2005; McDonald & Spielberger, 1983; Stanley, Novy, Bourland, 
Beck, & Averill, 2001; Suzuki, Tsukamoto, & Abe, 2000).  In the SA scale of STAI, the 
total score is the weighted sum of the 20 responses and ranges from 20 to 80: low anxiety 
(20-39), moderate anxiety (40-59), and high anxiety (60-80) (Speilberger, et al., 1983). 
Demographic data form. 
 The demographic data form, prepared by the investigator, was used to generate 
information on general demographic features.  These included questions about, for 
example, gender, age, income, and education.  The complete demographic questionnaire 
can be found in Appendix B.   
3.5 Protection of Human Subjects 
 Individuals with CVD who were 30 or older were not considered a vulnerable 
population for this study.   However, measures were taken to ensure protection of human 
subjects.  The first step was allowing voluntary participation and assuring confidentiality.  
Initially the principal investigator (PI) or the research assistant (RA) approached the 
patients admitted for outpatient invasive cardiac procedures at Hahnemann University 
Hospital in Pennsylvania and invited them to participate in the study.  The patients were 
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assured that their participation was voluntary and that they could withdraw at any time 
without any consequences.  Confidentiality was guaranteed and potential subjects were 
selected based on the study’s inclusion and exclusion criteria.  A brief explanation of the 
purpose, protocol, risks, and benefits of the study were given to the patient.  After giving 
an opportunity to ask questions and accurately verbally state the purpose of the study and 
the expectations from the participants of the study, they were asked to complete the 
questionnaire provided.  All communications were conducted in the privacy of the 
patient's examination room with access to healthcare staff responsible for the person’s 
care and assurance of HIPAA compliance.   
 No personal identifiers were connected with the data.  Instead of using the name 
of the study participant, a code number was assigned, as an identifier, to all the 
information received.  The investigator linked the code number of the data received from 
the patient while logging the information.  The PI managed all information obtained 
and/or identifying records.  A hardbound copy was secured in a locked, password- 
protected computer and file cabinet in the researcher's home and could be kept for a 
minimum of seven years, with access only to the research team.  Electronic data was 
stored on computer in PI's locked office.  Data was protected by password and security 
systems including network firewall technologies to prevent unauthorized external access 
to data repositories.  This process protects the participants’ rights to privacy and 
confidentiality. 
 Data was collected and analyzed exclusively for this study.  All data collected and 
analyzed were used specifically for research purposes and was protected from disclosure 
outside the research team, thus minimizing the risk for individual participants.  An 
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institutional review board approval was obtained from Drexel University to protect the 
subjects in the study.   
3.6 Risk and Benefits 
 There was a mild to moderate risk of psychological and physical stress involved 
in this study.  The involved risk was that the participants may become anxious or fearful 
while answering the questionnaire.  They may also experience fatigue during the process.   
If these experiences happened, the participants decided whether to terminate answering 
the questionnaire at any time to rest or to choose not to continue in the study.  To 
minimize the risks/harm, detailed information on the nature of the study and the 
participant's involvement was discussed.  Before the study actually began, the 
participants were made aware of the possible risk and their ability to withdraw from the 
study at any point without any consequence.  Any untoward or unforeseen risk would 
have been reported immediately to the Office of Research Compliance at Drexel 
University and the supervising professor.  However, there was no risk incurred in this 
study.  In case of any acquired risk, appropriate treatment within the limits of that 
normally offered by the Hahnemann preprocedural unit was arranged to be provided.  If 
the person required care beyond the capabilities of the unit, then the participant was 
referred to other resources such as a hospital emergency room or a mental health clinic.  
No other medical treatment or financial compensation for injury from participation in this 
project was available.  Participants were responsible for any expenses incurred by referral 
required for management of untoward events during this study.  
 39 
3.7 Inclusion of Women and Minority Subjects 
 Both female and male participants of any racial or ethnic background who met the 
study’s inclusion criteria and who did not present with any of the exclusion criteria were 
eligible to participate in the study.  Since it was a consecutive sample, an equal number of 
female and male subjects were not obtained.  
3.8 Inclusion of Children 
 No children were recruited for the study, as children were not included in the 
population of interest.  
3.9 Data and Safety Monitoring Plan 
 This study did not implement any phase I, II, or III clinical trials, thus a formal 
data and safety monitoring plan was not proposed.  However, patients were admitted for 
invasive cardiac procedures by a cardiologist.  Thus all study participants were under the 
care of the cardiologist, and the name of the cardiologist was requested or confirmed at 
the time of data collection.   
3.10 Procedures 
 The PI or the RA approached each patient, while he or she was waiting for 
invasive cardiac procedures in an outpatient, preprocedural unit and invited the patient to 
participate in the study.  The PI/RA then briefly explained the purpose of the study and 
screened patients for eligibility.  Screening for dementia and frailty was done through 
verbal verification (see Appendix B).  Patients who were found to have dementia or 
frailty were excluded from the study.  Eligible patients who met the inclusion criteria and 
were willing to participate in the study were asked to complete the questionnaires and the 
sample selection was stratified by gender.  All participants completed the CAQ-R, 
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Spielberger STAI Form-Y, and the demographic form and returned it in a sealed 
envelope to the PI/RA.      
 Most participants were able to complete the questionnaires without assistance.  To 
minimize environmental factors, the participants were provided a quiet environment.  
Participants took approximately 15-20 minutes to complete the questionnaires.  All the 
patients completed the questionnaire on the day of their coronary angiography or EP 
study.  Incomplete questionnaires were not included in the study.  The PI/RA did not 
collect any of the patient’s identifiable information. 
3.11 Compensation to Subjects 
 No compensation was provided to the study participants.  Study participants could 
request the results of the study by contacting the PI as listed on the consent form.  
3.12 Benefit to Society 
 The anticipated benefit to the society is that the results from the study could be 
used to expand on the literature and knowledge of psychological experiences in cardiac 
preprocedural unit and to understand the factors that link to a better outcome.  The 
findings could also help physicians recognize and treat the psychological stressors of the 
targeted patients prior to their scheduled cardiac procedures and thus reduce the potential 
for associated complications.                                                                                                                                    
3.13 Data Analysis 
 All data analysis was performed on SPSS software (20.0 Version).  Prior to 
analysis, data was screened for data entry accuracy, and outliers were identified and 
validated.  Descriptive statistics were calculated on demographic factors and study 
 41 
variables in order to look at central tendencies and variability of the data.  Data 
transformation was applied for all skewed distributions.  
  This study focused on four specific aims.  Different statistical analysis methods 
were used to evaluate the following aims.  
Aim 1: Determine differences in levels of cardiac anxiety, state anxiety, and trait anxiety 
between male and female patients undergoing an outpatient cardiac procedure after 
controlling for previous history of an outpatient cardiac procedure. 
The working hypothesis is that compared to males, female patients undergoing 
outpatient invasive cardiac procedures experience higher levels of cardiac anxiety, state 
anxiety, and trait anxiety. 
Aim 2: Determine the differences in cardiac anxiety, state anxiety, and trait anxiety 
between patients with and without a history of heart disease and HTN admitted for 
elective invasive cardiac procedures in an outpatient preprocedural unit after controlling 
for previous history of an outpatient cardiac procedure. 
The working hypothesis is that patients with a history of heart disease and HTN 
could have higher levels of cardiac anxiety, state anxiety, and trait anxiety compared to 
those with no history. 
 For Specific Aim #1 and Aim #2, the analysis of covariance (ANCOVA) 
statistical analysis method was used to evaluate the effect of variables (cardiac anxiety, 
state anxiety, and trait anxiety) and to determine the difference in their levels among the 
two groups, male and female patients, and between patients with or without a history of 
heart disease and HTN controlling for prior history of outpatient cardiac procedure as a 
covariant.  Descriptive statistics on all demographic factors and variables were done to 
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observe central tendencies and variability of the data.  Additional tests such as Chi 
Square analysis and t-test was done to find difference between sociodemographic 
variables, health history, and gender. 
Aim 3: Analyze association among cardiac anxiety, state anxiety, and trait anxiety in 
patients admitted for elective invasive cardiac procedures in an outpatient preprocedural 
unit.  
The working hypothesis is that there could be significantly strong positive 
correlation among cardiac anxiety, state anxiety, and trait anxiety in patients admitted for 
elective invasive cardiac procedures in an outpatient preprocedural unit. 
 For Specific Aim # 3, a Pearson correlations analysis was used to assess the 
strength of the relationship among cardiac anxiety, state anxiety, and trait anxiety and 
also to help identify the pertinent predictor variables for regression in order to minimize 
the possibility of committing Type I error in multiple regression analyses.   
Aim 4: Determine what health factors and socio-demographic variables best predict 
cardiac anxiety, state anxiety, and trait anxiety in patients admitted for elective invasive 
cardiac procedures in an outpatient preprocedural unit. 
The working hypothesis is that health factors like history of cardiac and EP 
procedure, heart disease, HTN, smoking, depression, use of alcohol and recreational 
drugs as well as socio-demographic factors like education, age and annual income could 
predict the level of cardiac anxiety, state anxiety, and trait anxiety in patients admitted for 
elective invasive cardiac procedures in an outpatient preprocedural unit. 
 For Specific Aim #4, due to large number of explanatory variables which may or 
may not be relevant for making predictions about the independent variable, a step-wise 
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regression analysis method was used which allowed optimization of the prediction model 
with adequate power.  This method was used to predict the association between health 
factors, socio-demographic variables and independent variables (cardiac anxiety, state 
anxiety, and trait anxiety).   Stepwise regression combines forward selection of the 
independent variables that are the best predictors of the cardiac anxiety, state anxiety, and 
trait anxiety and backward elimination that removes the variables with the smallest t 
statistic (p = .10).  The process continues until no more variables are removed (Forthofer, 
Lee, & Hernandez, 2006).  
3.14 Chapter Summary 
 This chapter described the research design, methodology used in sampling, 
instruments used for data acquisition, and the statistical methods used for data analysis.  
It has also explained the procedure involved in data collection and the data safety 
monitoring plan.  Patients who were frail, demented, and less than 30 years or more than 
89 years of age were excluded from the study.  A power analysis was done to determine 
the sample size necessary to test the hypotheses and minimize a Type II error.  The 
instruments used for the measurement of the study variables have good reliability and 
validity.  The methods used for data analysis in this study include ANCOVA, Pearson 
correlation and a stepwise regression.  The results of the study and discussion are 
discussed in Chapter 4 and 5. 
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4. RESULTS 
 This chapter presents an overview of the survey responses and description of the 
socio-demographic characteristics of the sample followed by findings from the analytic 
testing of specific aims.  A summary of the findings is provided at the end of the chapter. 
4.1 Survey Response 
 The participant recruitment flow chart for this study is presented in Figure 2.  A 
total of 113 people attempted the survey.  Once responses were gleaned for missing data, 
cases with more than ten percent missing data were excluded from further analyses.  For 
responses with less than ten percent missing data, a list wise deletion approach was 
adopted.  In a list wise deletion approach, cases with missing data for a particular variable 
were excluded from the analyses involving that variable, but were included in analyses 
involving other variables.  A total of 21 respondents either did not provide adequate 
information or did not meet the inclusion criteria of the study.  Consequently, these 
respondents were excluded from the study, and the remaining 92 responses were eligible 
for further analyses. 
 
Figure 2: Participant Recruitment Flow Chart   
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4.2 Socio-demographic Characteristics 
 Table 2 provides a summary of the socio-demographic characteristics of the 
survey respondents.  In those instances where data was missing, statistics were reported 
for available data.  The majority of the respondents were older adults (Mean = 59.5 years, 
SD = 13.7), Caucasian (n = 52, 57%), split in gender between male (n = 53, 57.6%) and 
female (n = 39, 42.4%) patients, with over ten years of education (Mean = 12.5, SD = 
3.7).  Approximately a third of the respondents were retired (n = 30, 32.6%), while a third 
were still employed (n = 34, 37.2%).  Fewer than half were still married (n = 31, 33.7%), 
while the rest were mostly single (n = 22, 23.9%) or divorced (n = 20, 21.7%).  The most 
frequently reported annual household income was under $15,000 (n = 31, 33.7%) while 
only a few reported making over $100,000 (n = 7, 7.6%). 
 
 
Table 2 
Socio-Demographic Characteristics of the Sample (N = 92) 
  N = 92 
Variable  Mean 
Standard 
Deviation 
Age (years)  59.5 13.7 
Years of Education 12.5 3.7 
  Frequency Percentage 
Gender Male 53 57.6 
 Female 39 42.4 
    
Race White 52 56.5 
 Black/African American 31 33.7 
 Asian/Pacific Islander 2 2.2 
 
American Indian/Alaska 
Native 
1 1.1 
 Hispanic/Latino 3 3.3 
 Two or more Races 1 1.1 
 Others 1 1.1 
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Marital Status Single (Never Married) 22 23.9 
 Married 31 33.7 
 Divorced 20 21.7 
 Widow/Widower 12 13 
 Separated 3 3.3 
 Living with Significant Others 4 4.3 
    
Employment Employed/self-employed 34 37.9 
 Retired (Mandatory) 30 32.6 
 Unemployed 9 9.8 
 Out of work/Disabled  17 18.4 
 Student 2 2.2 
    
Annual Income Under $15,000 31 33.7 
 $15,000-$24,999 7 7.6 
 $25,000-$34,999 7 7.6 
 $35,000-$49,999 15 16.3 
 $50,000-$74,999 16 17.4 
 $75,000-$99,999 2 2.2 
  $100,000 and over 7 7.6 
    
  
 Pertinent health history of the respondents is summarized in Table 3.  Three out of 
every four respondents reported having HTN (n = 71, 77.2%), while two thirds reported 
having heart disease (n = 60, 65.2%).  Just over half reported getting a cardiac 
catheterization (n = 53, 57.6%), while a select few had an EP study (n = 15, 16.3%).  
Only a few reported a prior history of anxiety (n = 17, 18.5%) and depression (n = 21, 
22.8%), and even fewer reported a prior history of stroke (n = 7, 7.6%).  Less than a 
quarter reported being smokers (n = 22, 23.9%), and a few had a prior history of 
recreational drugs (n = 6, 6.5%).  Most participants reported not being on psychiatric 
medication at the time of participation (n = 70, 76.1%). 
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Table 3 
Health History of the Participants (N = 92) 
Variables        Frequency         Percent 
Heart Disease No 32 34.8 
 Yes 60 65.2 
    
Hypertension No 21 22.8 
 Yes 71 77.2 
    
Prev. Catheterization No 39 42.4 
 Yes 53 57.6 
    
Stroke No 85 92.4 
 Yes 7 7.6 
    
Prev. EP study No 77 83.7 
 Yes 15 16.3 
    
Anxiety No 75 81.5 
 Yes 17 18.5 
    
Depression No 71 77.2 
 Yes 21 22.8 
    
Smoking No 70 76.1 
 Yes 22 23.9 
    
History Rec. Drug No 86 93.5 
 Yes 6 6.5 
    
Psych Meds None 70 76.1 
 Anxiety 4 4.3 
 Depression 13 14.1 
  Bipolar 5 5.4 
    
  
 The main outcome variables of this study were cardiac anxiety (CA), state anxiety 
(SA), and trait anxiety (TA).  The mean (standard deviation), minimum and maximum 
values of the CA scores, TA scores, and SA scores, for the entire sample are presented in  
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Table 4.  The mean score for CA was 27.9 (10.6) out of a possible score of 72 implying 
that the overall level of CA in the sample was low.  The SA and TA scores were in the 
mid - 40’s range out of a possible score of 80 implying moderate levels of SA and TA 
among the participants.  However, Chi Square analysis and t-test has not shown any 
statistically significant difference between sociodemographic and health history variables 
among male and female patients. 
 
Table 4 
Descriptive Information for the Outcome/Criterion Variables in the Study (N = 92) 
  N Minimum Maximum Mean Std. Deviation 
Cardiac Anxiety Score 92 3 52 27.9 10.6 
State Anxiety Score 92 28 62 45.3 6.5 
Trait Anxiety Score 92 29 59 44.3 5.2 
 
 
4.3 Reliability Analysis  
The Reliability Coefficient (Cronbach’s Alpha) for the CA Scale (CAS), The 
Spielberger State-Trait Anxiety Inventory Form-Y (STAI-Y) and the TA and SA 
Subscales of the STAI-Y were computed to determine the internal consistency reliability 
of the items that were aggregated to derive the scores.  Internal consistency reliability 
reflects the correlation among items and the correlation of each individual item with the 
total score.  This index ranges from 0.00 to 1.00.  A value that approaches 0.90 is 
considered high, and the scale can be considered highly reliable (Portney & Watkins, 
2009).  Scales with Cronbach’s alpha of less than 0.60 are considered less reliable 
(George & Mallery, 2003).  Data analysis from this study indicated a Cronbach’s alpha of 
0.89 for the CAS and 0.60 for the overall STAI-Y inventory.  SA and TA Subscales of 
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the STAI-Y had a Cronbach’s alpha of 0.59 and 0.34 respectively.  Therefore, for the 
current study, the STAI-Y SA subscale was borderline and the TA subscale was less 
reliable. 
4.4 Specific Aims 
 Prior to testing each hypothesis, data was checked, and it did meet the 
assumptions of parametric statistics.  These included scale level data for the dependent 
variables, independent observations, and normal distribution of the dependent variables.  
Assumptions specific to each statistical test were also tested and met. 
 Specific Aim 1: Determine differences in levels of cardiac anxiety, state anxiety, 
and trait anxiety between male and female patients undergoing an outpatient cardiac 
procedure after controlling for previous history of outpatient cardiac procedure. 
 The working hypothesis is that compared to males, female patients undergoing 
outpatient invasive cardiac procedures experience higher levels of cardiac anxiety, state 
anxiety, and trait anxiety. 
 Separate analyses of covariance (ANCOVA) revealed that after adjusting for 
previous history of cardiac procedure, no statistically significant differences (p > .05) 
were noted between male and female patients in their level of cardiac anxiety, state 
anxiety, and trait anxiety.  Table 5 presents the unadjusted and adjusted means and 
standard deviations for male and female for their CA, SA, and TA.  As evident from the 
group means presented in Table 5, the hypotheses that females have higher level of CA, 
SA, and TA than males were not supported. 
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Table 5 
Adjusted and Unadjusted Mean (SD) for Cardiac Anxiety, State Anxiety and Trait Anxiety 
for Males and Females After Adjusting for Previous Cardiac Procedure (N = 92) 
 
   Unadjusted Adjusted* 
  n Mean (SD) Mean (SD) p value
a
 
Cardiac Anxiety Male 53 28.3 (10.9) 28.1 (10.6) .78 
 Female 39 27.2 (10.3) 27.5 (10.5)  
State Anxiety Male 53 44.7 (6.2) 44.7 (6.4) .32 
 Female 39 46.2 (6.7) 46.1 (6.6)  
Trait Anxiety Male 53 44 (4.4) 44.1 (5.1) .92 
 Female 39 44.3 (5.9) 44.2 (5.1)  
* Adjusted means are based on ANCOVA analyses with previous cardiac procedure as a 
covariate 
a 
The p values for the adjusted means are calculated for the ANCOVA. 
 
  
 Specific Aim 2: Determine the differences in cardiac anxiety, state anxiety, and 
trait anxiety between patients with or without history of heart disease and HTN admitted 
for elective invasive cardiac procedures in an outpatient preprocedural unit after 
controlling for previous history of an outpatient cardiac procedure. 
 The working hypothesis is that patients with a history of heart disease and HTN 
could have higher levels of cardiac anxiety, state anxiety, and trait anxiety compared to 
those with no history. 
 The ANCOVA revealed that after adjusting for previous history of cardiac 
procedure, statistically significant differences (p < .05) were noted in levels of SA, only 
between those with and without history of heart disease.  No differences were noted 
between the groups for CA and TA.  Table 6 presents the unadjusted and adjusted means 
and standard deviations for those with a history of heart disease for their CA, SA, and 
 51 
TA.  As evident from the adjusted group means, both SA and TA were higher in those 
with a history of heart disease compared to those who did not have any heart disease; 
however only the difference in SA was statistically significant.  
 Effect size was calculated from the group mean scores to standardize the 
difference in CA between those with and without heart disease.  An effect size is 
considered to be the smallest immediate effect that is clinically meaningful in the target 
population for the outcome measure; in this case the CA score.  The calculation revealed 
that although not statistically significant, the difference in CA between the groups 
corresponds to an effect size of 0.38.  This, according to Cohen’s index of effect size 
(Cohen’s d), is close to a medium effect in keeping with his definition for difference 
between cell means.  The relatively small sample of subjects without any heart disease 
may have contributed to a Type II error whereby, although not statistically significant due 
to lack of power, the difference between the two groups is large enough to be clinically 
relevant.  
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Table 6 
Adjusted and Unadjusted Mean (SD) for Cardiac, State and Trait Anxiety for Those With 
and Without Heart Disease After Adjusting for Previous Cardiac Procedure (N = 91) 
 
   Unadjusted Adjusted* 
  n Mean (SD) Mean (SD) p value
a
 
Cardiac Anxiety Heart Disease 60 24.2 (10.6) 24.7 (10.1) .07 
 No Heart Disease 31 29.4 (9.8) 29.1 (10.3)  
State Anxiety Heart Disease 60 46.5 (6.3) 46.8 (6.4) .003** 
 No Heart Disease 31 42.8 (6.2) 42.2 (6.5)  
Trait Anxiety Heart Disease 60 44.3 (5.7) 44.5 (5.3) .25 
 No Heart Disease 31 43.6 (4.9) 43.2 (5.4)  
* Adjusted means are based on ANCOVA analyses with previous cardiac procedure as a 
covariate 
** p < .05 the p values for the adjusted means are calculated for the ANCOVA. 
 
 
 Separate ANCOVA analysis also revealed that after adjusting for previous history 
of cardiac procedure, statistically significant differences (p < .05) were noted in levels of 
CA between those with and without history of HTN.  No differences were noted in SA 
and TA between hypertensive and nonhypertensive groups (see Table 7). 
 
Table 7 
Adjusted and Unadjusted Mean (SD) for Cardiac, State, and Trait Anxiety for those With 
and Without HTN After Adjusting for Previous Cardiac Procedure (N = 92) 
 
   Unadjusted Adjusted* 
  N Mean (SD) Mean (SD) p value 
Cardiac Anxiety Hypertension 71 29.4 (10) 29.3 (10.1) .02** 
 No Hypertension 21 22.7 (11.2) 23 (10.5)  
State Anxiety Hypertension 71 45.1 (7) 45.8 (6.6) .70 
 No Hypertension 21 46 (4.4) 45.2 (6.4)  
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Trait Anxiety Hypertension 71 44.1 (5.4) 44.1 (5.1) .87 
 No Hypertension 21 44.4 (4.1) 44 (5.3)  
* Adjusted means are based on ANCOVA analyses with previous cardiac procedure as a 
covariate 
** p < .05 the p values for the adjusted means are calculated for the ANCOVA. 
 
 
 Due to the potential confounding effect of hypertension and heart disease on 
anxiety, separate Chi-square analyses were conducted to assess differences between 
males and females in their frequency of heart disease and hypertension in the sample.  
Frequencies of those reporting heart disease and hypertension differentiated by gender 
are presented in Table 8.  As evident, males and females did not differ significantly (p > 
0.05) in their frequency (percentage) of those with heart disease and hypertension. 
However, it should be noted that a higher percentage of males were reported being 
hypertensive and with heart disease.  Thus the potential confounding effect of these two 
conditions on the comparison of anxiety levels between males and females cannot be 
ruled out completely. It is likely that the higher incidence of heart disease and 
hypertension among males may have contributed towards elevating their anxiety levels. 
 
Table 8 
Comparison of Frequency of Heart Disease and Hypertension by Gender (N = 92) 
 
Variable  
Frequency (%) 
p value Males 
(n = 53) 
Females 
(n = 39) 
Heart Disease Yes 37 (71) 23 (59) 0.23 
Hypertension Yes 43 (81) 28 (72) 0.29 
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 Specific Aim 3: Analyze association among cardiac anxiety, state anxiety, and 
trait anxiety in patients admitted for elective invasive cardiac procedures in an outpatient 
preprocedural unit.   
 The working hypothesis is that there could be a significantly strong positive 
correlation among cardiac anxiety, state anxiety, and trait anxiety in patients admitted for 
elective invasive cardiac procedures in an outpatient preprocedural unit. 
 Separate Pearson product moment correlation (r) analyses were conducted to 
assess the strength of the relationship among CA, SA, and TA.  The analysis revealed 
statistically significant correlation between SA and TA of moderate strength (r = 0.55; p 
< .05).  CA was only fairly correlated with SA (0.22) and TA (0.25), although both 
relationships were statistically significant (p < .05) as shown in Figure 3. 
 
Figure 3: Correlation among Cardiac, State, and Trait Anxiety  
 
Note. Created by Shajimon, B. 2013 
r = 0.55 
r = 0.25 r = 0.22 
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 Specific Aim 4: Determine what health factors and socio-demographic variables 
best predict cardiac anxiety, state anxiety, and trait anxiety in patients admitted for 
elective invasive cardiac procedures in an outpatient preprocedural unit.   
 The working hypothesis is that health factors like history of cardiac and EP 
procedure, heart disease, HTN, smoking, depression, use of alcohol and recreational 
drugs as well as socio-demographic factors like education, age and annual income could 
predict the level of cardiac anxiety, state anxiety, and trait anxiety in patients admitted for 
elective invasive cardiac procedures in an outpatient preprocedural unit.  
 Three separate stepwise regression analyses were conducted to determine the best 
linear combination of socio-demographic and health factors that predicted CA, SA, and 
TA scores in the sample.  A step-wise approach was deemed appropriate since it allowed 
for the optimization of the prediction model with adequate power, and since only the 
predictors that significantly contributed towards the prediction were included in the final 
model. 
 In the case of CA, the predictors included income, history of heart disease, HTN, 
and use of recreational drugs.  These predictors were selected since they were at least 
moderately correlated (0.2 or higher) with CA.  Results from the step-wise regression 
analysis revealed that annual income, when entered by itself in the regression model, was 
the most significant predictor of CA (F1, 85 = 9.4, p = .003); however the combination of 
annual income and history of heart disease significantly improved the predictability of the 
model (F2, 84 = 8.4, p = .001).  This was evident from the increase of the R
2 
value from 
0.10 to 0.17 indicating that when both annual income and history of heart disease were 
entered as predictors, the model explained 7% more variance in CA scores.  None of the 
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other predictors strengthened the prediction model or contributed towards explaining the 
variance any further.  Multicollinearity tests indicated that the assumption of no 
multicollinearity among the predictors was not violated.  This was supported by the 
correlation between the predictors being less than 0.70 and the high tolerance values of 
the predictors in the regression analysis.  Tolerance values more than 1 - R
2 
(0.84) 
indicated negative multicollineraity (Leech, Barrett, & Morgan, 2005).  As seen in  
Table 9, the negative beta coefficient for income suggests that CA decreases as income 
increases, whereas the positive beta coefficient for heart disease suggests that CA is 
higher in people that have heart disease.  
 
Table 9 
Stepwise Regression Summary Showing the Two Models of Best Fit with the Predictor 
Beta Coefficients, Level of Significance, and the 95% Confidence Interval of the Beta 
Coefficients 
 
Model Predictors Beta Significance 95.0% CI for Beta 
    Lower Bound Upper Bound 
1 (Constant) 32.5  28.7 36.3 
 Annual Income -1.6 0.003* -2.7 -0.6 
      
2 (Constant) 29.0  24.4 33.5 
 Annual Income -1.7 0.001* -2.7 -0.7 
 Heart Disease 5.7 0.011* 1.4 10.1 
*p < .05 Criterion: Cardiac anxiety score 
  
 Step-wise regression analysis for SA revealed that history of heart disease was the 
only significant predictor of SA (F1, 85 = 7.8, p = .007) with an R
2
 value of 0.08 indicating 
that the model was able to explain 8% variance in SA scores.  As seen in  
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Table 10, the positive beta coefficient suggests that SA is higher in those with heart 
disease.  Finally, a prediction model could not be developed for TA as none of the 
predictors made a significant contribution to the prediction. 
 
Table 10 
Stepwise Regression Summary Showing the Predictor Beta Coefficient, Level of 
Significance, and the 95% Confidence Interval of the Beta Coefficients 
 
Model Predictor Beta Significance 95.0% CI for Beta 
    Lower Bound Upper Bound 
1 (Constant) 42.6  40.3 44.8 
 Heart Disease 3.9 0.007* 1.1 6.7 
*p < .05 Criterion: State anxiety score 
 
 Chi-square analysis was also performed to test whether annual income was 
different between males and females since annual income has been shown to be a 
predictor of anxiety.  As seen in Table 11, no significant difference (p > 0.05) was noted 
between males and females in their distribution of annual income. 
 
Table 11 
Comparison of Frequency of Annual income by Gender (N = 92) 
 
Variable  
Frequency (%) 
p value Males 
(n = 53) 
Females 
(n = 39) 
Annual Income Under $25,000 21 (40) 24 (61) 0.06 
 $25,001 - $50,000 16 (30) 6 (15)  
 $50,001 - $75,000 10 (19) 6 (15)  
 Over $75,000 6 (11) 3 (9)  
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4.5 Chapter Summary 
 Of a total of 113 people who attempted the survey, 21 respondents either did not 
provide adequate information or did not meet the inclusion criteria of the study.  The 
remaining 92 respondents were deemed eligible for study participation.  Respondents 
were primarily older adults (Mean = 59.5 years, SD = 13.7), Caucasian (n = 52, 57%), 
both male (n = 53, 57.6%) and female (n = 39, 42.4%) patients, with over ten years of 
education (Mean = 12.5, SD = 3.7).  Three out of four respondents reported having HTN 
(n = 71, 77.2%), while over two thirds reported having heart disease (n = 60, 65.2%).  
Just over half reported getting a cardiac catheter (n = 53, 57.6%), while a select few had 
an EP procedure (n = 15, 16.3%).  Other infrequently reported medical history included 
anxiety (n = 17, 18.5%), depression (n = 21, 22.8%), and stroke (n = 7, 7.6%). 
 The Reliability Coefficient (Cronbach’s Alpha) for the Cardiac Anxiety Scale 
(CAS), The Spielberger State-Trait Anxiety Inventory Form-Y (STAI-Y) and its TA and 
SA Subscales of the STAI-Y revealed that for the current study both the scales provided 
reliable data; however, the data from the STAI-Y TA anxiety subscale in particular may 
be less reliable. 
 Separate analyses of covariance (ANCOVA) revealed that after adjusting for 
previous history of cardiac procedure, no statistically significant differences (p > .05) 
were noted between male and female patients in their level of CA, SA, and TA.  
Therefore the hypotheses that female patients have higher level of CA, SA, and TA than 
male patients were not supported.  
 Another set of ANCOVA analyses revealed that after adjusting for previous 
history of cardiac procedure, statistically significant differences (p < .05) were noted in 
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levels of SA only between those with and without history of heart disease.  No 
differences were noted for CA and TA.  Statistically significant differences (p < .05) were 
noted in levels of CA between those with and without history of HTN.  No differences 
were noted in SA and TA between hypertensive and nonhypertensive groups. 
 Separate Pearson product moment correlation (r) analyses that were conducted to 
assess the strength of the relationship among CA, SA and TA anxieties showed a 
statistically significant correlation among the three variables; however, the relationship 
between SA and TA was of moderate strength (r = 0.55; p < .05), while the correlation of 
CA with SA (r = 0.22) and TA (r = 0.25) was fair. 
 Results from the step-wise regression analysis revealed that annual income, when 
entered by itself in the regression model, was the most significant predictor of CA (F1, 85 
= 9.4, p = .003); however, the combination of annual income and history of heart disease 
significantly improved the predictability of the model (F2, 84 = 8.4, p = .001).  Step-wise 
regression analysis for SA revealed that a history of heart disease was the only significant 
predictor of SA (F1, 85 = 7.8, p < .007).  A prediction model could not be developed for 
TA as none of the predictors made a significant contribution to the prediction. 
4.6 Chapter Conclusion 
 A summary of the most significant results in this study are as follows: 
1. In both male and female patients, a statistically significant difference was not 
noted in their levels of CA, SA, and TA. 
2. Individuals with a history of heart disease had a higher level SA and TA; 
however, only the difference in SA was statistically significant. 
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3. A diagnosis of HTN was associated with a higher level of CA.  No differences 
were noted in SA and TA between hypertensive and nonhypertensive groups. 
4. This study found a positive correlation among CA, SA, and TA, a relatively weak 
correlation between CA with SA and TA, and a strong correlation was found 
between SA and TA.  
5. Finally, a disparity in anxiety level was noted in individuals according to annual 
income status and a history of heart disease.  These factors were found to be the 
most significant predictors of CA.   CA decreases as income increases, whereas 
CA is higher in people who have heart disease.  However, a history of heart 
disease was the only significant predictor of SA revealing that SA is higher in 
those with heart disease.  A prediction model could not be developed for TA, as 
none of the predictors made a significant contribution to the prediction. 
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5. DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
5.1 Introduction 
 This chapter could discuss the results of the study.  The chapter begins with a 
discussion of the research question, specific aims, research hypothesis, and central 
hypothesis identified in the previous chapter.  In addition, this chapter could include a 
discussion of the sample and post hoc analysis and a discussion of the operationalization 
of the conceptual and theoretical framework.  The chapter concludes with a discussion 
about the study’s significance for nursing practice, its limitations, and recommendations 
for future studies, closing with an overall study and chapter summary. 
5.2 Research Discussion 
The purpose of this study was to determine the difference in cardiac anxiety (CA), 
state anxiety (SA), and trait anxiety (TA) in male and female patients admitted for 
invasive cardiac procedures in a hospital-based preprocedural unit so that the specific 
anxiety could be identified and properly treated and managed.  The diagnosis and 
treatment of cardiovascular disease is most commonly achieved by invasive cardiac 
procedures.  The anticipation of being diagnosed with CVD, the possibility of having a 
coronary artery bypass surgery, the possibility of death, and other procedure related 
complications elicit anxiety.  Prior studies have demonstrated that individuals with 
cardiac diseases or cardiac symptoms experience elevated health-related anxiety and that 
this contributes to dysfunctional bio-behavioral processes like persistent worry or 
rumination about illness.  These studies further demonstrate that individuals, especially 
with cardiac diseases or cardiac symptoms, may experience high level of health related 
anxiety preoperatively such as cardiac, SA, or TA anxiety that significantly produced 
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physiological variations requiring increased hospitalizations for cardiac symptoms 
(Aikens, Michael, Levin, Myers, & et al., 1999; Szekely et al., 2007).  Several studies 
have reported the presence of anxiety prior to cardiac procedures (Astin et al, 2005; 
Lunden et al, 2006).  However, there is no study that looked at the most prevalent type of 
anxiety in the preprocedural unit.  This is the first study to look at the three different 
types of anxieties and find the most prevalent type of anxiety that is present in the 
preprocedural unit where patients are waiting for invasive cardiac procedures. 
5.3 Specific Aims and Research Hypothesis 
There were four specific study aims.  These study aims explored the three types of 
anxiety in a preoperative setting among both men and women.  
Aim 1: Determine differences in levels of cardiac anxiety, state anxiety, and trait anxiety 
between male and female patients undergoing an outpatient cardiac procedure after 
controlling for previous history of an outpatient cardiac procedure. 
Hypothesis1:  When compared to males, female patients undergoing outpatient invasive 
cardiac procedures could experience higher levels of CA, SA, and TA anxiety. 
Hypothesis 1 was not supported.  This study found that CA, SA, or TA anxiety levels, on 
average, were similar between male and female patients; however, a slightly higher level 
of SA and TA was noticed in female compared to male patients.  Although other studies 
have found that the female patient’s preoperative level of anxiety was significantly higher 
than the male patient’s preoperative level since they experienced more psychological 
stress and anxiety (Gallagher et al., 2010; Heikkila et al., 1999; Heikkila et al., 1998: 
Sykes, Evans, Boyle, McIlmoyle, & Salathia, 1989).  The results in these studies might 
have been biased, as there were fewer female compared to male patients in the sample, 
 63 
which would provide less reliable data due to smaller sample size.  Furthermore, the 
sample in these prospective studies which were conducted outside U. S. had a 
predominantly higher male to female ratio of 3:1 and were an average of 66 years of age, 
80% married, and 60% employed compared to the present study done in the U. S. with 
relatively more female participants with a 3:2 male to female ratio, average age of 60, 
over 10 years of education, two-thirds employed, and mostly single or divorced. 
 Anxiety scores were low and, on average, were similar in this study among male 
and female patients which may be attributed to the following factors: younger mean age 
(60 years), relatively comparable sample size, and being single/divorced.  This finding 
can be supported by the results of 2006 Lau et al.’s study of 1058 young twins (age 8-16) 
which showed no age or gender difference in SA and TA.  The results of few other 
studies also have emphasized that single and young male and female patients are less 
fearful and anxious compared to married, older couples since they are more independent 
and responsible for their own care.  It is also possible that being single or divorced, both 
male and female patients without any significant others in life, prepare themselves 
mentally to overcome the diagnosis and outcome and handle stress at the same level.  
They are less affected by social acceptance by either sex and accept total responsibility 
for themselves compared to older adults.  Married couples, especially women, are very 
dependent on their spouses and tend to get more anxious in anticipation of the lack of 
support, particularly when they are diagnosed with a life threatening heart disease for 
which they have to undergo lifelong treatment (Con, Linden, Thompson, & Ignaszewski, 
1999). 
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Aim 2: Determine the differences in cardiac anxiety, state anxiety, and trait anxiety 
between patients with or without history of heart disease and HTN admitted for elective 
invasive cardiac procedures in an outpatient preprocedural unit after controlling for 
previous history of an outpatient cardiac procedure.  
Hypothesis 2:  Patients with history of heart disease and HTN could have higher levels 
of cardiac, SA and TA anxiety compared to those with no history. 
Hypothesis 2 was partially supported.  CA was significantly higher in patients with HTN 
and SA was significantly higher in those with heart disease only.  TA was not different 
for any of the health conditions.  
 Statistically, no significant difference was noted in CA and TA in those with 
history of heart disease.  However, a statistically significant difference was seen in SA in 
patients with and without heart disease.  Individuals with heart disease were found to 
have a high level of SA compared to those with no heart disease.  Yet a small difference 
was noted in the level of CA in patients with and without heart disease which is clinically 
relevant.  It is interesting that patients without heart disease were found to have a higher 
level of CA than those with a history of heart disease, although TA was found to be 
slightly higher in those with a history of heart disease.  Patients who have not been given 
a diagnosis of heart disease or have a previous history of heart disease, but who are in the 
process of being diagnosed with invasive cardiac procedures are most likely to be 
concerned about their heart and its functioning based on the belief that heart disease 
could lead to negative consequences (e.g., pain, death; Eifert, Zvolensky, & Lejuez, 
2000).  Therefore, these patients are more likely to have high level of heart focused CA 
than those with a known history of heart disease, who already have the experience of 
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living with heart disease and its consequence.  These individuals may have made 
adjustments in their lives and have learned to live with their diagnosis.  Hence, the 
patients with heart disease were less focused on their heart and its functioning compared 
to those without heart disease.   
 In contrast, patients with heart disease may be more focused on the procedure and 
its related complications.  As a result, they experienced a higher level of state.  These 
findings are supported by the data from the study by Eifert, Zvolensky, & Lejuez (2000) 
which reported that patients without a diagnosis of heart disease but with chest pain 
symptoms (cardiac or noncardiac related) have a hyper-vigilance and response bias for 
cardiac sensations and events.  Thus the patients who experience cardiac related 
symptoms and are anticipating a diagnosis of heart problems after the invasive cardiac 
procedure could likely be more vigilant on their cardiac sensation, which could lead to 
CA and which shares similar characteristics to phobic anxiety.  
 On the other hand, patients with known heart disease who were admitted for 
further diagnosis or treatment of their existing cardiac problem are more focused on the 
procedure and its associated complications, which can lead to SA in preprocedural unit.  
It was also found that patients with cardiac related symptoms for more than four months 
report intense autonomic sensations generally and cardiac symptoms specifically, 
compared to those without a chronic history (Aikens Michael, Levin, Myers, & et al., 
1999).  Since CA and SA share similar characteristics of phobic anxiety which are 
triggered by specific fear cues responsible for producing anxiety, they are associated with 
an elevated risk of death related to heart disease as phobic anxiety (Haines, Imeson, & 
Meade, 1987; Kawachi, Colditz, & et al., 1994).  These are important findings because it 
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means that regardless of the history of heart disease, all patients should be assessed and 
managed for CA, SA, and TA since a difference may exist.  However, in this study the 
difference between the two groups was large enough to be clinically relevant, as indicated 
by a medium effect on Cohen’s index of effect size (0.38).  The relatively small sample 
of subjects without any heart disease (n = 31) compared to those with heart disease (n 
=60) may have contributed to a Type II error whereby, although not statistically 
significant due to lack of power, the difference between the two groups is large enough to 
be clinically relevant.  Since CA is a type of phobic anxiety that is relevant to a number 
of clinical and medical syndromes and produces psychological and physiological distress, 
along with their chronic characteristic, it may increase the patient susceptibility to 
ventricle fibrillation leading to an increased risk for sudden cardiac death (Albert et al., 
2005). 
 In this study, a statistical difference was not noted in SA and TA between 
hypertensive and nonhypertensive groups.  However, a statistically significant difference 
was noted in levels of CA between those with and without history of HTN.  Patients with 
a history of HTN were found to have a higher level of CA than those with no history of 
HTN, and there was absolutely no difference in SA and TA between these two groups.  
Patients admitted for invasive cardiac procedures who reported HTN in their past medical 
history are aware of their hypertensive status and thus they were more likely to be 
anxious in the preprocedural unit.  Findings from previous studies have shown a 
relationship between HTN and SA (Jeter, Bush, & Porter, 1998; Jhalani et al, 2005; 
Spruill et al., 2007).  Studies have reported that the perception of being hypertensive was 
associated with greater anxiety in a clinical setting independent of the true blood pressure 
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level (Spruill et al., 2007).  In addition, the findings from Spruill et al. (2007) also 
revealed that the patients labeled or diagnosed with HTN had a high level of SA 
compared to those who were nonhypertensive.  
 HTN or high blood pressure is known to increase the risk of CVD (Gerend et al., 
2004).  Vasan et al.’s (2001) study done with the Framingham Heart Study cohort (N = 
6,859) provided further evidence on the association between HTN and incidence of CVD.  
They found that patients with a higher baseline blood pressure had an increase in 
cardiovascular event rate (myocardial infarctions, stroke, congestive heart failure), 
including death from CVD.  The anticipation of receiving negative or frightening 
information from their clinicians related to HTN and CVD and the perceived threat 
associated with fatal or catastrophic consequences resulted in high anxiety (Spruill et al., 
2007).  The individual’s response to health threats has significant effect on both cognitive 
and emotional process.  Evidence supported that in patients with HTN, the perception of 
the associated health threat attributed to serious medical condition would activate the 
emotional processing pathway which elicited anxiety and led to cardiovascular events 
(Gerend et al., 2004).  Studies have also found that patients who had been informed or 
labeled with HTN diagnosis have an increased sympathetic response to stress compared 
to those without the diagnosis of HTN (Rostrup, Mundal, Westheim, & Eide, 1991). 
Therefore, the diagnosis or labeling of HTN in patients should be done very carefully, 
since it may provoke unintended negative consequences.  Patients who are truly 
hypertensive and are treated for HTN should be assessed and managed for anxiety in 
clinical settings (Gerend et al., 2004).  Based on the result from this study, management 
of CA and SA in patients with and without a history of heart disease and HTN is 
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recommended prior to hospital admission for invasive cardiac procedures to prevent 
unintended negative consequences.  Early assessment and management of anxiety could 
help tailor specific interventions, manage anxiety symptoms appropriately, and prevent 
pathologic and physiological changes and adverse outcomes pre and postprocedures. 
Aim 3: Analyze associations among CA, SA, and TA in patients admitted for elective 
invasive cardiac procedures in an outpatient preprocedural unit.   
Hypothesis 3: There could be a significantly strong positive correlation among cardiac 
anxiety, state anxiety, and trait anxiety in patients admitted for elective invasive cardiac 
procedures in an outpatient preprocedural unit. 
 Hypothesis 3 was partially supported.  There was a significant positive correlation 
among CA, SA, and TA in patients admitted for elective invasive cardiac procedures in 
an outpatient preprocedural unit.  Although a positive correlation was found among CA, 
SA, and TA, a relatively weak correlation was found between CA with SA (.22) and TA 
(.25), but a strong correlation was found between SA and TA (.55).  However, all 
correlations were statistically significant (p < .05) suggesting that preprocedural anxiety 
is a multidimensional construct consisting of parts of CA, SA, and TA.  Indeed, this is 
precisely what was found in Smoller and Tsuang’s (1998) study which indicated that 
anxiety was composed of various dimensions with underlying different aspects of 
vulnerability.  In this present study, it is evident that patients who came in for elective 
invasive cardiac procedures were more concerned about the procedure and complications 
than their heart health.  However, patients with TA were found to be more at risk for 
developing severe SA while in the preprocedural unit and CA in the outpatient clinic or 
doctor's office, because they were predisposed to respond to the threatening situation due 
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to the inherited TA.  Individuals with TA have characteristics called motives which are 
the dispositional tendencies or residues of past experience that are latent until the cues of 
the situation activate them (Spielberger et al., 1983).  TA acts as a trigger factor placing 
patients at high risk for developing SA and CA as it is associated with cognitive biases 
which have genetic underpinnings (Muris, Rapee, Meestsers, Schouten, & Geers, 2003).  
 Under threatening circumstances, genetically mediated TA disposition is 
expressed through the tendency to respond as SA, which is the product of interaction 
between the disposition and a stressor and which suggests that SA also has a genetic 
vulnerability to environmental stressors to produce anxiety symptoms (Endler & 
Kocovski, 2001; Lau et al., 2006; Spielberger, 1996).  Therefore, in the preprocedural 
unit, individuals with TA, when exposed to environmental stresses, could have an 
intensified level of SA.  In contrast, patients seen in clinics are not exposed to intensified 
environmental stressors.  Their visit to the clinic may be for routine follow-up care or for 
evaluation of heart related symptoms.  They anticipate going home after a check-up or 
obtaining a recommendation for further evaluation and treatment for their heart related 
problems.  In the clinic, when patients anticipate or are newly-given a diagnosis of heart 
disease or are being told about the poor prognosis of their existing heart problems that 
endanger their life, CA may develop, which intensifies over time and becomes chronic in 
nature. Studies have reported that anxiety was a known risk factor for progressive 
cardiovascular disease and cardiovascular events among medically managed patients 
(Gullette et al., 1997; Stengrevics et al, 1996; Couldiams et al., 2013).  Hence, a timely 
and appropriate diagnosis and treatment of the specific type of anxiety could perpetuate 
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less psychological and physiological impact in the procedural unit and outpatient 
cardiology office.  This could ultimately prevent pre and postprocedural complications.  
 The weak relationships among CA and TA in this study was likely due to the fact 
that the data obtained from the TA subscale was less reliable, which could be accounted 
for by the difficulty in interpretation of the questions as more than 50%  of the subjects 
had either high school (33%)  or a lower (21%) level of education.  It is possible that the 
subjects’ answers were biased with a lesser understanding of the questions.  Therefore, 
further research and development of the TA subscale is necessary to improve sensitivity 
for detecting TA. 
 In summary, it is evident that preprocedural anxiety is a multidimensional 
construct which positively correlates to the interrelated CA, SA, and TA although they 
differ in characteristics. It is evident that there is a statistically significant correlation 
between CA, SA, and TA although they differ in characteristics.  This finding suggests 
that individuals who are susceptible to anxiety may experience anxiety at any time as a 
response to a threatening situation.  The type and level of anxiety depends on the 
situation that activates them and the disposition of the stressors.  Therefore, an 
individualized intervention may be tailored with focus on the underlying stressors to 
provide effective treatment. 
Aim 4: Determine what health factors and socio-demographic variables best predict 
cardiac anxiety, state anxiety, and trait anxiety in patients admitted for elective invasive 
cardiac procedures in an outpatient preprocedural unit so that the specific anxiety can be 
identified and properly treated and managed.   
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Hypothesis 4: Health factors like history of cardiac catheterization and EP procedure, 
heart disease, HTN, smoking, anxiety, depression, use of alcohol and recreational drugs 
as well as socio-demographic factors like education, age, and annual income could 
predict the level of CA, SA, and TA in patients admitted for elective invasive cardiac 
procedures in an outpatient preprocedural unit.  
 Hypothesis 4 was also partially supported.  The stepwise regression analyses 
revealed that for CA, annual income and history of heart disease were significant 
predictors.  The results of this analysis indicated that an increase in annual income 
decreased the level of CA (β =-1.6, p = .001), whereas a history of heart disease in a 
patient increased the level of CA (β = 5.7, p = .011).  For SA, a history of heart disease 
was the only significant predictor.  SA was found to be higher in patients with a history 
of heart disease (β = 3.9, p = .007).  For TA, nothing contributed to the prediction. 
 Research has suggested that social factors such as poverty and unemployment 
increase the risk of heart disease due to unintended stress (Anderson & Armstead 1995; 
Pincus & Callahan, 1995).  Individuals with low income who either have a history of 
heart disease or experience heart related symptoms or anticipate a diagnosis of life-
threatening heart condition could be worried about the cost of treatment and life-
threatening events associated with untreated heart disease.  It is not surprising that 
symptoms related to heart disease may heighten anxiety, because these symptoms may 
make patients suspicious of being diagnosed with heart problems.  This heart-focused 
anxiety could give rise to CA which could become persistent and interfere with a person's 
daily life functioning.  The worries about heart disease, its effect on life and difficulty in 
adapting to lifestyle changes, and its life threatening consequences because of not getting 
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appropriate treatment due to no income or low income would likely produce intensified 
heart-focused CA.  Individuals with higher annual income may be optimistic about 
getting the best possible treatment for their heart problems and have better quality of life.  
They could go forth in life with less focus on heart disease, as a result, they could have 
less heart-focused anxiety.  
 This study has revealed that individuals with CA have a negative relationship with 
annual income and a positive relationship with a history of heart disease.  Primarily, 
individuals with heart disease are likely to be anxious because of their heart conditions.  
Therefore, when they are exposed to another stressful situation like being in the 
preprocedural unit for an invasive cardiac procedure, with anticipation of something 
unpleasant about to happen, a poor prognosis, or a life-threatening event, it may possibly 
provoke situational anxiety leading to intensified SA.  Annual income should have no 
effect in the preprocedural unit when patients are admitted for an elective procedure 
which has been preapproved by insurance company.  These individuals do not have to 
worry about the payment for the procedure unless they have no insurance plan and are 
planning to pay out-of-pocket.  This seldom happens, because invasive cardiac 
procedures are very expensive making them unaffordable to the truly uninsured.  
Therefore, annual income does not provoke SA in preprocedural unit.  The subjects in 
this study were admitted for an elective invasive cardiac procedure.  Since admission was 
possible only after the preapproval by the insurance company, information about their 
health insurance plan was not obtained.  As the subjects had no financial burden towards 
their procedure, a positive correlation between income and SA was not revealed. 
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 In summary, a history of heart disease could increase the level of SA in 
anticipation of the associated complications and poor prognosis during or after the 
procedure.  The names and a history or diagnosis of HTN could provoke CA.  Evidently 
annual income and a history of heart disease were found to be predictors for CA and heart 
disease alone was a predictor of SA.  Since TA is a personality trait with a genetic link, 
there were no social predictors unless a link with the family history was established.  
However, individuals with a history of heart disease who were more concerned about 
effective treatment, poor prognosis, and difficulty in adapting to lifestyle changes could 
experience higher levels of CA whereas in the preprocedural unit, patients experienced 
more SA due to the intense stressful environment.  Early and appropriate diagnosis of the 
specific type of anxiety could help in tailoring effective treatment and management thus 
reducing negative consequences.  
 Additional statistical analysis such as Chi Square analysis and t-test revealed that 
more than 50% of the subjects had a low level of education, high school or less.  
Individuals with low educational status or low health literacy may have increased anxiety 
that could result in unfamiliarity with the healthcare environment (Williams et al., 2013).  
These individuals are likely to have increased adverse events due to non-adherence to the 
postprocedural plan of care.  
5.4 Discussion of Sample 
 The subjects in the sample were predominantly Caucasians, approximately 60 
years old, single or divorced, educate at the high school level, mostly employed with an 
annual household income of under $15,000.  However, on average, women were 
significantly older than men and more women than men had a history of HTN, heart 
 74 
disease, which were found to be the predictors of anxiety.  Nevertheless, a majority of 
them did not report being on psychiatric medication at the time of participation in the 
study.  This sample might not truly represent the larger population, as it was recruited 
from a convenient setting in a large urban hospital.  Therefore, generalizability of the 
results may not be achieved.  
5.5 Attrition from Sample 
In the study sample, 21 respondents of a total of 113 people that attempted the 
survey either did not provide adequate information or did not meet the inclusion criteria 
of the study.  This is only about 19% of the total respondents who did not participate in 
the study.  The remaining 92 respondents were eligible for study participation.  There was 
no attrition bias in this study even though the sample had decreased, but it attained the 
estimated sample size in order to achieve 80% power to detect a difference of .5 in the 
mean. 
5.6 Marten’s Multi-Dimensional Anxiety Theory 
Anxiety is a discrete emotional experience, which may be described as having 
cognitive, neurobiological, and behavioral components.  It is conceptualized in many 
ways such as a trait, a state, a stimulus, a response, a drive, and a motive.  Anxiety states 
are characterized by “subjective feelings of tension, apprehension, nervousness, and 
worry, and the activation or arousal of the autonomic nervous system” (Spielberger et al., 
1983, p. 4). 
 Anxiety is found to be “influenced by the cultural milieu in terms of both the 
situational encounters that elicit anxiety and the manner and style in which the experience 
of anxiety is perceived and understood” (Endler, 1997, p. 137). Emotional arousal has 
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been related to various learning experiences including conditioning process.  Decades of 
neuroscientific and learning research indicate  that  anxiety reactions occurs as a result of 
higher-order conditioning of the autonomic nervous system to certain environmental 
events and situations.  Higher-order conditioning process forms the basis for human 
learning. As referred by C. Nezu, Martell, & A. Nezu (in press), higher-order 
conditioning includes the process of associative learning that occurs when a previously 
conditioned stimulus is paired with a new conditioned stimulus.  Research in associative 
learning have shown that common emotional experience that impact our daily life due to 
various stimuli can be partially linked to high conditioning.  Various stimuli (external or  
internal) may actually alter the sensitivity and reactivity of neuroendocrine system that 
mediates the stress response which may either produces heightened emotional arousal or 
lowers the threshold for arousal (as cited in C. Nezu, Martell, & A. Nezu).  However, 
learning behaviors of different individuals vary based on individual differences 
concerning temperament vulnerability, the impact of prior experiences, the impact of 
contextual variables during conditioning, and the impact of post-event variables (C. 
Nezu, Martell, & A. Nezu).  Studies have demonstrated that brain chemistry imbalances 
are also a very likely cause of anxiety disorders.  Evidence supports that people suffering 
from anxiety often have deregulation of neurotransmitters (brain chemicals) which 
includes serotonin, norepinephrine and gamma-aminobutyric acid (GABA).  These 
neurotransmitters may get activated with exposure to a potential dangerous stimulus 
(Borne, 2006; Brawman-Mintzer, & Lydiard, 1997). 
The cognitive processing of life stressors is linked to the activation of the 
amygdala, a part of the limbic system, which can ingrain itself with cognitive 
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conditioning.  This leads to difficulty in perceiving accurate cues for fear and can result 
in hyperactive anxiety states.  The amygdala has been related in the origin of anxiety 
disorders because it links emotion to physical reaction and memory.  The 
interconnections among the regions in the limbic system are responsible for recognition 
and activation of emotion-related behaviors, including fear and anxiety (Borne, 2006; 
Brawman-Mintzer, & Lydiard, 1997).  The neurotransmitters and neuropeptides mediate 
activation of such pathways and associated symptomatology.  Variations in anatomical 
activation and/or neurotransmitter action/sensitivity may be responsible for the different 
types of anxiety disorders (such as CA, SA, and TA), and these variations may partly 
result from genetic phenotypes and/or neuroendocrine stressors resulting from trauma 
(Kim &Gorman, 2005). 
 SA, TA, and CA are the multidimensional constructs that are the focus of this 
study, which involve both subjective aspects and physiological symptom manifestations 
of these three types of anxiety.  They are also explained using Martens' multi-
dimensional anxiety theory (MAT) which has identified the symptoms of cognitive and 
somatic anxiety.  In fact, anxiety symptoms are distinguished on three levels: cognitive, 
somatic, and behavioral (Mackenzie, 2010).  MAT explains the association among the 
symptoms of anxiety and the separation of cognitive from somatic anxiety (Martens, 
Burton, Vealy, Bump, & Smith, 1990).  Based on MAT, patients who experience anxiety 
(CA, SA, or TA) would follow a pattern of subjective feelings of tension and inadequacy 
combined with heightened arousal of their autonomic nervous system (Hackfort & 
Schwenkmezger, 1989).  According to MAT, the self-ruminated cognitions in patients 
with CA, SA, and TA developed from focusing on the inadequacies, potential failures, 
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and anticipation of being diagnosed with life-threatening CVD that is associated with 
cognitive anxiety.  This cognitive anxiety would then lead to emotional or autonomic 
responses causing sympathetic nervous system arousal resulting in somatic anxiety 
(Endler, 1983; Endler, Parker, Bagby, & Cox, 1991).  An increase in the sympathetic 
nervous system response would then escalate anxiety symptoms that would affect the 
person’s physiological hemodynamics and the physical, emotional, and psychological 
wellbeing (Mackenzie, 2010; Morris et al., 1981).  Therefore it is important to identify 
preprocedural anxiety to promote collaboration among cardiovascular physicians with 
psychiatric services to reduce emotional stress and reduce adverse events. 
 
Figure 4: Anxiety Theory 
 
Note. Created by Shajimon, B. 2013 based on anxiety theories. 
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 Using MAT, the specific subcomponents of CA, SA, and TA can be identified.  In 
patients with CA, the individual’s cognition and experience of cardiac-related symptoms 
along with his or her preconceived notion of aversive and dangerous nature of heart 
disease could elicit CA.  The sequence of events in CA include: a) an external or internal 
trigger or stimulus, b) perception of stimulus as a threat, c) apprehension, d) body 
sensation, e) interpretation as catastrophic sensation, and f) abnormal physiological 
change (see Figure 5).  SA is a function of the interaction between the person and 
situation variables (Endler, 1983; Endler at al., 1991) and between the interaction of a 
specific dimension TA (e.g., social evaluation) and a congruent situational threat.  Since 
individuals with TA have a predisposition to experience anxiety in different threatening 
situational contexts as in social evaluation, physical danger, ambiguous, (Endler, Hunt, & 
Rosenstein, 1962), loss, or conflict (Endler, 1983), they could have significantly 
increased SA when they are exposed to a congruent threat.  When TA and situational 
stress are not congruent, the experience of an increased SA does not occur (Endler et al., 
1991).  The low threshold TA will exhibit as CA and SA with higher threshold. The 
predisposition to a particular experience (as seen in TA), engagement in a particular 
behavior (as in CA) and the individual's actual response in a specific situation (as seen in 
SA), distinguishes CA, SA, and TA (Endler, 1983).  Although the cognitive elements in 
CA, SA, and TA differ, they predispose one to hyperarousal of the autonomic nervous 
system leading to somatic anxiety.  It has also been found that disordered autonomic 
regulation of the cardiovascular system is linked to coronary artery disease and sudden 
cardiac death (Clark, 1988).  Hence, when anxiety alters their autonomic tone, it is 
manifested by a decrease in vagal response and an increased sympathetic component, 
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thereby increasing the susceptibility to fatal ventricular fibrillation.  The reduced heart 
rate variability in patients with a high level of anxiety has been shown to predict sudden 
cardiac death (La Rovere et al., 2003).  Findings from Albert and colleagues’ (2005) 
study suggested that chronic rather than acute effects of anxiety on cardiac 
electrophysiology are found to cause fatal ventricular arrhythmia which is of great 
importance.  Evidently MAT establishes a relationship between anxiety and symptoms 
that affect an individual’s performance and wellbeing.  MAT similarly explains the 
multidimensional response of SA, TA, and CA that focuses on individual differences in 
the likelihood of experiencing somatic or cognitive symptoms.  Hence, we recognize that 
SA, TA, and CA are multidimensional both theoretically and empirically. 
Martens' MAT explicitly identifies and separates cognitive-worry and autonomic-
emotional dimensions of state, trait, and cardiac anxiety.  However, MAT also aids in the 
theoretical discussion of the relatedness among the association of the symptoms of 
anxiety and helps distinguish between different dimensions of state, trait, and cardiac 
anxiety.  Since anxiety has been associated with increasing the sympathetic nervous 
system activity and leading to cardiac instability with an increase in susceptibility to 
ventricular fibrillation and sudden cardiac death (Albert et al; 2005; Kop et al., 2004), it 
is important to correctly diagnose and appropriately treat a person’s specific type of 
anxiety disorder in order to decrease the negative consequences associated with the 
different types of anxiety.  The culmination of the recognition of associated symptoms of 
anxiety would be particularly helpful in differentiating the type of anxiety appropriately 
and tailoring an effective treatment plan. 
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Figure 5: Sequence of Events in CA 
 
Note. Created by Shajimon, B. 2012 
 
5.7 Significance of the Study for Nursing Practice 
 The concept of preprocedural anxiety, particularly CA, has far-reaching 
importance to nursing practice.  Professional nurses as direct care providers and Master’s 
Advanced Practice Nurses (APN) and Doctoral Advanced Practice Nurses (DNP/DrNP) 
as educators are in a critical position to make an impact in the lives of patients 
experiencing cardiac specific anxiety.  Given the potentially serious complications 
associated with untreated anxiety, precise and timely diagnosis is warranted, which rarely 
occurs as a part of assessment in a preprocedural unit or cardiology clinic.  Patients with 
high levels of anxiety need to be identified preoperatively and offered interventions 
directed to reduce anxiety associated complications (Carr, Brockbank, Allen, & Strike, 
2006).  Nurses, including staff nurses and master and doctoral level nurse clincians play 
an important role in assessing patients in the preprocedural unit prior to any procedures.  
APNs and DNP/DrNPs have a better chance of screening patients for CA, SA, and TA 
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than physicians, because psychologists or cardiologists do not routinely screen patients 
undergoing cardiac procedures in outpatient or inpatient settings.  In urban hospitals, it is 
extremely common for the APNs to round on patients and participate in both the 
admission to and discharge from the outpatient cardiac setting.  These nurse clinicians are 
well positioned to help identify patients at-risk for sustained psychological distress.   
 Preprocedural physiological and psychological distress increases the duration of 
the cardiac procedure, sedative requirement (Nilsson et al., 2009), and the risk of CVD 
and cardiac mortality in patients with diagnosed cardiac disease, and it is associated with 
a poor long-term prognosis (McCann et al., 2010).  Patients with an elevated heart–
focused CA are likely to become more upset and worried about their heart related 
sensations and, as a result, tend to anxiously monitor their heart and pulse, avoid 
activities believed to bring on symptoms, repeatedly seek reassurance from healthcare 
professionals resulting in costly cycles of reassurance seeking doctors’ visits and medical 
examinations (Aikens Michael, Levin, Myers, & et al., 1999; Eifert, Zvolensky, & 
Lejuez, 2000).  DNP/DrNP clinicians in particular should be well versed in the evidence 
that supports establishing a therapeutic environment that could reduce the stress that 
elicits anxiety in clinical settings.  As DNP/DrNP are educated to be active change agents 
in the healthcare system with a focus on improving the health of aggregate populations 
(Dreher, & Smith Glasgow, 2011), it is expected that they will seek to change or improve 
hospital environments or health procedures.  Currently this role is under-recognized and 
underused, but it is emerging as more nurses in particular earn a doctor of nursing 
practice degree.  Since patients with anxiety have increased medical need inflating the 
cost of care, assessing for anxiety among individuals with psychological distress and 
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behavioral problems is paramount.  In the preprocedural unit, DNP/DrNP and APNs 
could use the opportunity to screen and diagnose patients with psychological distress and 
provide appropriate referral and treatment, but it is incumbent that they be educated 
appropriately to do this in their formal graduate nursing education.  DNP/DrNPs and 
APNs should also be alert to patients with complex needs or potentially challenging 
assessments which might require physician or psychologist diagnosis.  Appropriate 
interventions by these clinicians could reduce physical ailments, help patients cope with 
disease, decrease their lengths of stay and postoperative pain medication, increase patient 
and family member satisfaction with the process, and improve prognosis (Kruzik, 2009).  
Anxiety is a treatable disorder; early treatment not only improves symptoms but 
also helps to prevent its other associated medical problems.  DNP/DrNP and APNs need 
to focus on preventive efforts by identifying risk factors that produce anxiety in cardiac 
patients in outpatient preprocedural unit and cardiology clinics.  Nurse clinicians, in 
diverse clinical settings such as the outpatient cardiovascular unit, need to incorporate 
brief, quick, and reliable anxiety screening assessment instrument into the assessment 
process.  Routine screening for anxiety would enable early identification of clinically 
relevant anxiety and rapid initiation of interventions.  Since anxiety is widely prevalent in 
general population, it thus represents a new frontier in the prevention of CVD.  Clinicians 
must be tactical in identifying anxiety symptoms in patients who are at increased risk for 
sudden cardiac death.  Future research should focus on finding the pathological levels of 
anxiety in patients exposed to stressors that most likely provoke anxiety that could 
increase the risk of CVD such as low socioeconomic status, unfamiliar health care 
environment, or a diagnosis HTN. 
 83 
 As previously stated, it is important to reemphasize that this study highly 
recommends that there is a need for doctoral advanced practice nurse clinicians to be 
diligent and adequately equipped with skills and resources to systematically identify 
those “at risk” and work with psychologists (or other trained mental health professionals) 
to develop specific interventions.  However, evaluation of the clinically relevant anxiety 
disorder in preprocedural settings may direct appropriate treatment as it reflects a 
physiological milieu that mediates clinical outcomes. Since a significant amount of time 
in the preprocedural unit before the actual procedure is used to conduct routine 
assessments and obtain consent by the practitioners, a need remains for future research to 
evaluate the use of a short anxiety evaluation questionnaire that would focus on the three 
most prevalent types of anxiety, CA, SA, and TA, in a cardiac preprocedural unit. 
5.8 Implications for Cardiac Medicine and Psychology 
 Identification of the most common or dominant anxiety in cardiac preprocedural 
unit and cardiology clinics is important for clinicians and nurses because it will help 
clinicians prioritize and develop appropriate and effective interventions.  An 
interdisciplinary approach to identify and appreciate the anxiety-CVD relationship is 
important because it may yield a greater understanding of the interrelationship of the 
psychological, physiological, and disease process.  By identifying the relevant anxiety, 
clinicians may identify likely stressors and offer appropriate treatments to hopefully 
effectively lower anxiety level.   
 To accomplish this goal, creating a state-of-the-art medical environment including 
cardiologist, psychologist, and doctoral advanced practice nurses in treating patients with 
cardiac related symptoms or disease process may help in early recognition of anxiety 
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related stressors and offer appropriate treatment.  Promoting early collaboration among 
cardiovascular physicians and psychiatric services may help in providing effective 
treatment for cardiopulmonary & psychological distress.  It may further prevent anxiety 
related adverse events by identifying risk factors and enhance recovery and decrease risk 
cardiac events.  The multidisciplinary approach in the medical environment may also 
prevent pre and post procedural complications by early intervention in patients 
undergoing invasive cardiac procedures.  Furthermore, facilitating appropriate referral 
and treatment regardless of their medical status may promote optimal treatment with 
fewer medications and reduce adverse events. 
 It is evident that the state of the mind plays  a huge part in  our well-being.  
Therefore, it is important for clinicians to make efforts to breakdown the cycle of 
worsening symptom severity, psychological and physiological distress, and healthcare 
utilization in cardiac patients. Convincing the cardiology community of the value of the 
state-of-the-art medical environment, which includes collaboration with psychologists, is 
more comprehensive that  just the strict treatment of cardiovascular disease in isolation 
from its cardiac disease’s psychological manifestations. A collaborative effort may 
effectively manage the bio-psycho-social influences on heart disease and increase the 
quality of life of those with CVD and perhaps even decrease the prevalence of disease.  
Psychologist may not only help these patients to deal with stress but may also help them 
comply with treatment regimens.  Clinicians’ awareness should be increased on the 
influence of psychological well-being on symptom relief and its effects on adherence to 
treatment regimen. Multidisciplinary sharing of knowledge and collaboration especially 
between psychology and cardiology will benefit the patients enormously.  This 
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interdisciplinary collaboration may increase practitioners' ability to heal patients by 
improving coronary treatment and prevention.  The multidisciplinary team can work with 
patients across the diagnostic continuum from those who are at risk for CVD to those 
who have experienced a cardiac event.  Thus, the focus in these settings should be on 
facilitating behavioral change in an effort to reduce cardiovascular risk factors.  
Collaborative effort will lead to coordinated intervention which may help in optimizing 
the cardiac patients physical, psychological, and social functioning and reducing 
morbidity and mortality (Molinari, Compare, & Parati, 2006). 
5.9 Study Limitation 
The findings of this study were inferred considering the several existing limitations.  
This study mainly had four limitations:  
1. Potential selection bias related to recruitment due to use of a convenience sample and 
relative small sample size, although adequate power was used to evaluate the main 
hypotheses.  However, the lack of power due to use of multiple predictors to find any 
relationship with the outcome variable and unpredictability on the number of 
variables that needed to be controlled reduced the sample size.  A larger sample 
would have eliminated Type II error. 
2. Self-report measures which provide only real time subjective descriptions of 
behaviors and feelings of the respondents and individuals still may not have 
responded truthfully.  Therefore, it has a potential for inaccuracy over time. 
3. There could be uncertainty in the respondents answer, since it was unknown if the 
stress was independent of anxiety as stress level was not measured.  Moreover, the 
cross-sectional nature of the study also did not allow detection of relative stability of 
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the observed effects.  However, it was evident that there was no modulation in 
anxiety due to drug therapy, because the majority reported not being on psychiatric 
medication at the time of participation (n = 70, 76.1%), only 24% were on medication 
for anxiety, depression, or bipolar disorder.  
4. There was a lack of generalizability due to a homogeneous population recruited from 
a single site.  Selection bias cannot be eliminated due to the design of the proposed 
study; bias can be minimized through the random selection.  Although all patients 
were scheduled to undergo elective cardiac procedures, the sample was not totally a 
homogenous group, because more than half of the group had experienced a prior 
cardiac procedure.  The samples were also predominantly Caucasian and were older 
adult patients with a relatively high CVD diagnosis.  Therefore, it is unclear whether 
these results would be generalizable to other locations with different ethnicity, cardiac 
diagnoses (e.g., postcoronary artery bypass graft surgery or automatic implantable 
cardioverter device) or age group (e.g., middle-age adult or frail elderly).  
 However, the study data represented an important addition to previously 
published studies on this topic where men predominated in study recruitment.  The 
stepwise non-regression method employed to detect predictors of anxiety was strength; 
however, this method reduced sample size and most likely the descriptive capacity of the 
regression model.  Based on the findings, it would be reasonable and appropriate to 
provide tests across time in future work on this topic.  Perhaps patients with CA should 
be followed longitudinally when they are first given a diagnosis of a potential cardiac 
disease.  Follow-up measures of their disease trajectory could help better understand the 
effects of CA over time. 
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5.10 Recommendations 
 Anxiety, especially CA has been under-appreciated in patients undergoing 
invasive cardiac procedures.  An explicit assessment and recognition of specific heart–
focused and situational anxiety in patients with and without heart disease in various 
medical settings such as primary care clinics, emergency departments, and preprocedural 
units could be helpful in defining our understanding of psychological problems and 
useful in tailoring specific treatment plans.  It is crucial that clinicians diligently assess 
patients for anxiety in their routine examination and provide appropriate treatment to 
enhance recovery and decrease patients’ risk of cardiac events.  Routine assessment of 
patients’ anxiety levels is recommended so that accurate diagnoses can be made on 
targeted patients and resources focused on specific groups rather than on most patients 
who experience fairly low levels of anxiety.  Early recognition of psychological 
problems, particular those that fall within the realm of the DSM-IV-TR could facilitate 
appropriate referral and treatment of such patients regardless of their medical status.  
Therefore, it is important to have a quick and more accurate diagnosis to minimize 
functional impairment, increase quality of life, and reduce healthcare costs.  An accurate 
recognition and diagnosis of specific anxieties in a medical setting, especially the 
preprocedural unit, can help clinicians relate core psychological and physiological 
processes and focus treatment on an identified clinically relevant anxiety.  Evaluation and 
treatment of CA in patients, especially those who are undergoing invasive cardiac 
procedures, may very well prevent complications, reduce burden on the health care 
system, and reduce emotional and financial burden to those experiencing noncardiac 
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chest pain.  Appropriately targeted treatment should reduce symptoms, associated 
complications, and prevent relapse.  
5.11 Future Study in Nursing 
The following should be the focus of future research: 
1. Explore the extent to which preprocedural CA and SA impacts outcomes in patients 
undergoing invasive cardiac procedures. 
2. Address development of a more specific and brief scale that could be used in 
preprocedural units to identify clinically relevant CA, SA, and TA so that effective 
treatments can be offered immediately. 
3. Focus on finding the pathological levels of anxiety in patients exposed to stressors 
such as low socioeconomic status, unfamiliar health care environment, and a 
diagnosis of HTN that could most likely provoke anxiety, which would increase the 
risk of CVD. 
4. Investigate the effect of elevated levels of CA on health outcomes in the context of 
the increasing number of patients undergoing both elective CATH/PCI and EP study. 
5.12 Chapter Summary 
This study mainly focused on preprocedural anxiety in patients waiting for invasive 
cardiac procedures in an outpatient preprocedural unit.  The main outcome variables of 
the study were CA, SA, and TA as anxiety is composed of various dimensions underlying 
different aspects of vulnerability to the phenotype (Smoller & Tsuang, 1998).  In this 
sample, a moderate level of SA and TA were found compared to a low level of CA.  The 
data from this study indicated that patients in a preprocedural unit have a higher level of 
SA compared to CA.  This is possibly due to the fact that in the preprocedural unit 
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patients are most concerned and focused on their situation, the procedure they are waiting 
to undergo, and the associated complications and outcome of the procedure, all of which 
can elicit SA.  The significant correlation of SA with a negative psychological state and 
physiological event has further stress that SA should be recognized in the preprocedural 
unit and treated appropriately to reduce associated complications.  CA on the other hand 
is more a chronic type of anxiety which is more likely to develop when patients first 
experience cardiac related symptoms and/or are given a possible diagnosis of heart 
disease.  This anxiety develops in the outpatient setting, and it persists over time 
increasing the risk of cardiac arrhythmias and death related to heart disease.  Therefore, it 
is important to diagnose and manage this condition appropriately in the outpatient 
cardiology clinic or doctor's office where the patient is been seen.  Clinicians must take 
the initiative in addressing the psychosocial issues in cardiac outpatient clinics or offices 
as well as the inpatient units to prevent pathological, psychological, and physiological 
events that could contribute to an increase in cardiac mortality.  Albeit, when clinicians 
identify the specific type of anxiety in patients in an outpatient cardiac clinic or 
preprocedural unit, they could possibly help patients manage their anxiety by addressing 
the specific cause of their anxiety and offering appropriate treatment.  In the outpatient 
cardiology clinic, CA should be more prevalent due to its chronic nature mainly focusing 
on the heart and heart related symptoms.  However, in the preprocedural unit, SA could 
be more common due to patients’ concern with the situation, procedural outcome, 
anticipation of adverse effects and complications, and even life-threatening events.  
Providing information on the possible cause and its management could be reassuring to 
the patient (Lunden et al., 2006). 
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5.13 Study Conclusion 
 Anxiety and CVD frequently coexist and evidence has suggested that anxiety may 
be an independent risk factor for CVD, along with leading to poorer outcomes.  In 
addition, individuals who experience symptoms related to cardiac disease, develop heart–
focused CA.  When they are admitted into the preprocedural unit to undergo invasive 
cardiac procedures to be diagnosed either or treated for a cardiac disease, they may 
experience intense SA due to environmental stress, procedure, complications, outcome, 
and being given the diagnosis of life-threatening heart disease.  The findings from this 
study have supported the findings of other studies reported in the past that patients with 
TA express a high level of SA, an acute stress disorder under threatening circumstance, 
and they develop chronic illness focused CA while being cared for heart related 
symptoms in the clinic.  It is important to identify and support the vulnerability 
mechanism in the expression of TA as symptoms of SA and CA.  Epidemiological 
evidence has suggested that anxiety increases the risk of developing heart disease.  
However, chronic anxiety increases the risk of heart disease by influencing health 
behaviors such as smoking, promoting atherogenesis by increasing risk of HTN, 
triggering fatal coronary events, either through arrhythmia, plaque rapture, vasospasm, or 
thrombosis.  Since anxiety is associated with abnormal cardiac autonomic control, it may 
increase the risk of fatal ventricular arrhythmias (Haines et al., 1987; Kawachi, Colditz, 
& et al., 1994; Kawachi, Sparrow, & et. al., 1994; Kubanski et al., 1998).  Patients who 
experience symptoms related to heart disease or have been diagnosed with a heart 
problem experience persistent heart-focused anxiety or CA which could become chronic 
in nature and progress to a dangerous level requiring long-term psychotherapy. Because 
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CA is a type of chronic anxiety type, it may also increase the risk of heart disease and 
related mortality.  From this study all variables (CA, SA, and TA) had been identified as 
potentially influential.  Therefore, patients who are seen routinely in cardiology clinics or 
admitted for invasive cardiac procedures in an out-patient preprocedural unit should be 
assessed for anxiety.  Interventions to prevent or reduce anxiety should be provided since 
higher level of anxiety is distressing for patients and is predictive of poor outcome.  
Nurse clinicians in particular should contribute towards disentangling the 
multidimensional nature of anxiety in the cardiac preprocedural unit by incorporating 
anxiety assessment with their routine care. 
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APPENDIX A: LETTER OF SUPPORT 
 
Letter from Dr. Charles D. Spielberger 
Binu Shajimon, MSN, CRNP-BC 
Nursing Student, Drexel University 
Philadelphia, PA 
 
Dear Mr. / MS Shajimon, 
Thanks for your email confirming that you received my signed letter, giving you 
permission to reproduce and use our State-Trait Anxiety Inventory (STAI) in your 
dissertation.  I sincerely hope that our anxiety measures could prove helpful in your 
research and look forward with great interest to hearing about the results of your study 
when these are available. Very best wishes.   
 
Charles D. Spielberger, PhD, ABPP, Distinguished Research Professor and Director,  
Center for Research in Behavioral Medicine and Health Psychology, Department of 
Psychology PCD 4118G University of South Florida, 4202 East Fowler Avenue, Tampa, 
FL 33620-7200.  Phone (813) 974-2342; Fax (813) 974-4617; Email:  spielber@usf.edu 
 
 
 
 
From: Binu Shajimon <bbbshajimon@yahoo.com> 
Subject: Drexel Doctoral student - Request for STAI 
To: spielber@usf.edu 
Date: Wednesday, September 7, 2011, 10:57 PM 
 
Dear Dr. Spielberger, 
I am currently a second year nursing doctoral student at Drexel University in 
Philadelphia, PA. I am interested in the topic "Pre-op state and trait Anxiety" for my 
dissertation. This email is to kindly requesting permission to use the STAI form-Y 
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developed by you for my research. Kindly let me know, in elderly population age over 70 
years can I use this? If not, what would you recommend? All information on STAI form -
Y is for population under 70 yrs. Are there any other formalities to obtain the 
questionnaire? Please advise and do not hesitate to contact me should you require any 
further information. Thank you.   
Sincerely,  
Binu Shajimon, MSN- CRNP-BC 
Hahnemann University Hospital 
215-762-4585 (W) 
267-253-0136 (C) 
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Letter from Dr. Georg Eifert 
From: Georg Eifert <geifert@chapman.edu> 
To: Binu Shajimon <bbbshajimon@yahoo.com> 
Sent: Wed, May 11, 2011 11:12:19 AM 
Subject: Re: Drexel Doctoral Student 
 
Dear Binu, 
Please go ahead and use the questionnaire — just acknowledge source and authorship in 
all written documents. 
Best wishes for your research. 
 
Georg H. Eifert, Ph.D.  
Professor & Head of Psychology Faculty  
Crean School of Health & Life Sciences | Schmid College of Science | Chapman 
University  
Orange | CA 92866 | USA | phone: 714-628-2729 | fax: 714-997-6780  
http://www.chapman.edu/SCS/HLS/faculty/eifert.asp 
 
 
 
 
From: bbbshajimon@yahoo.com   
To: Georg Eifert geifert@chapman.edu 
Subject: CAQ 
Date: 5/10/11  
 
Dear Dr. Eifert,  
I am currently a second year nursing doctoral student at Drexel University in 
Philadelphia, PA. I am interested in the topic "Cardiac Anxiety" for my dissertation. This 
email is to kindly to request permission to use the Cardiac Anxiety Questionnaire 
developed by you for my research. Kindly let me know, if there are any other formalities 
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to obtain the questionnaire. I would also greatly appreciate it if you would give me your 
expert opinion / suggestion on my proposed dissertation question. My question is to 
measure the level of cardiac anxiety vs. preprocedural (state) anxiety in patients 
undergoing outpatient cardiac procedures and stratify based on age, gender and race. In 
your opinion is there a gap existing in this area or do you have any other suggestions. 
Please advise and do not hesitate to contact me should you require any further 
information. Thank you.   
Sincerely,  
Binu Shajimon, MSN-CRNP-BC 
Hahnemann University Hospital 
215-762-4585 (W) 
267-253-0136 (C) 
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APPENDIX B: QUESTIONNAIRES 
 
 
Cardiac Anxiety Questionnaire-Revised (CAQ-R) 
 
The questionnaire, Cardiac Anxiety Questionnaire-Revised (CAQ-R), utilized in this 
research study is a copyrighted document.  Therefore, the questionnaire is not included in 
this dissertation Appendix.
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The Spielberger State-Trait Scale Form–Y (STAI-Y)  
 
The questionnaire, The Speilberger State-Trait Scale Form-Y (STAI-Y 1), utilized in this 
research study is a copyrighted document.  Therefore, the questionnaire is not included in 
this dissertation Appendix.
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The questionnaire, The Speilberger State-Trait Scale Form-Y (STAI-Y 1), utilized in this 
research study is a copyrighted document.  Therefore, the questionnaire is not included in 
this dissertation Appendix.
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Demographic Questionnaire 
ID# ______    
Scheduled Procedure: □ Cath /PCI _________ □ EP S__________   
First Invasive Cardiac procedure:  □ Yes  □ NO 
Gender:  □ Male  □ Female 
Age (years)*  _______ 
Race: 
 □ White    □ Black / African American 
 □ Asian/ Pacific Islander  □ American Indian /Alaska Native    
  □ Hispanic or Latino   □ Native Hawaiian   
□ Two or More Races   □ Some other race    
Ethnicity:   
□ Hispanic White or Latino  □ Hispanic Nonwhite  □ Others  
Marital Status:  
 □ Single (never married)   □ Married   □ Divorced   
□ Widow/Widower    □ Separated  □ Living with significant 
other 
□ Recognized civil or domestic partnership  □ Other 
Years of education: _______ 
□ Some High school or less 
□ High School graduate  
□ Some college or associate degree 
□ College Graduate /Bachelor's degree  
□ Post graduate / professional degree 
Employment:  
□ Employed   □Part Time   □Full Time 
□ Unemployed   □ Self Employed   □Out of work  due to health 
issues        
□ Disabled            □Student                       □ Retired (mandatory or 
voluntary) 
Annual Household Income:  
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□ Under $15,000  □ $15,000 to $24,999  □ $25,000 to $34,999 
□ $35,000 to $49,999  □ $50,000 to $74,999  □ 75, 000 to $99, 999 
□ $100,000 and over  
Check all the problems you had or currently have:  
□ Heart disease  □ High blood pressure  □ Stroke   
□ Previous Cardiac Catheterization  □ Previous Electrophysiological procedures      
  □ Anxiety    □ Depression    □ Smoking    
□ History of Recreational Drug use   □ History of Alcohol use 
□ Recreational Drug use within the past 72 hours □ Alcohol use within the past 72 hours 
List all medications that you are taking: 
______________ ___________________ ___________________   
______________ ___________________ ___________________  
______________ ___________________ ___________________  
______________ ___________________ ___________________  
______________ ___________________ ___________________   
______________ ___________________ ___________________   
______________ ___________________ ___________________  
(This is a modification/adaptation of a noncopyrighted questionnaire 
http://grants.nih.gov/grants/guide/notice-files/not-od-01-053.html; 
http://pubdb3.census.gov/macro/032007/hhinc/new06_000.htm)                          
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Screening Questions 
ID#____ 
•  Are you diagnosed with or currently been treated for dementia? □ Yes    □ No  
  
• Are you diagnosed with or currently been treated for the following conditions? 
□ Congestive heart failure  □ MI   □ Angina  □ diabetes   □ PVD  □ high blood 
pressure            □ Cancer □ COPD  □ Stroke  □ kidney failure/dialysis
 □ Arthritis 
□ Any other major health conditions_______________ 
 
 1.   Do you feel tired/fatigue and depend on others for carrying out the activities 
of daily life? 
 □ Yes  □ No   □ Need some Help         
2.  Because of your health or a physical condition, do you have any difficulty with the 
following physical activities: 
a) Walk 10ft 
  □ No difficulty  □ Some difficulty    □ A Lot of difficulty  
 □ Unable to do 
b) Open your medication bottles 
 □ No difficulty  □ Some difficulty    □ A Lot of difficulty  
 □ Unable to do 
c) Bathing or Shower 
 □ No difficulty  □ Some difficulty    □ A Lot of difficulty  
 □ Unable to do 
3.   Any Weight loss  > 10 lbs lost unintentionally in prior year        □ Yes 
 □ No   
>3 CRITERIA (LOT OF DIFFICULTY OR UNABLE TO DO) PRESENT IS POSITIVE FOR FRAILTY AND 
COULD BE EXCLUDED FROM THE STUDY 
(Based on Cardiovascular Health Study Measure) 
(Rockwood, Fox, Stolee, Robertson, & Beattie, 1994; Pel-Littel, Schuurmans, Emmelot-Vonk, & Verhaar, 2009).   
  
